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In the developing and adult central nervous system (CNS), oligodendrocyte (OL) 
biology is controlled intrinsically by transcription and epigenetic factors, and 
extrinsically by neural activity and signaling molecules.  Neural activity regulates 
OL development through the release of neurotransmitters and soluble molecules 
such as glutamate, ATP, and LIF.  The epigenome controls gene expression 
through DNA methylation and post-transcriptional repression by microRNAs 
(miRs).  These signaling pathways are dysregulated following CNS injury or 
disease, making them potential targets for therapeutic intervention.  However, the 
effect of patterned neural activity on OL development and epigenetic 
mechanisms after spinal cord injury (SCI) is not fully understood.  We found that 
the application of functional electrical stimulation (FES) after a complete mid-
thoracic SCI in adult rats enhances proliferation of oligodendrocyte progenitor 
cells (OPCs) in the lumbar spinal cord in a frequency-dependent manner.  Our 
data show that SCI alters miR expression caudal to the lesion level, and that FES 
treatment delays the injury-induced repression of OL-specific miR-338 and miR-
23a.  Furthermore, FES promotes the upregulation of miR-19b and DNA 
methyltransferases 1 and 3b, which are associated with neurogenesis and 
oligodendrogenis in the CNS.  Taken together, these results suggest that neural 
activity regulates OL development in the injured spinal cord by modulating 
epigenetic mechanisms.   
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Chapter 1: Introduction 
1.1 Spinal Cord Injury Pathology 
Traumatic spinal cord injury (SCI) occurs to approximately 12,000 people in the 
United States every year, and the number of people with SCI that are currently 
alive is projected to increase to over 276,000 by 2014 (Devivo, 2012).  The 
average age at the time of injury is 37.1 years, and men are injured 3-4 times 
more often than women.  Overall, the leading cause of traumatic SCI is still motor 
vehicle crashes (Devivo, 2012), followed by accidents at work and during sports 
or recreation.   
In traumatic SCI, the major injury types include impact with and without 
compression, laceration, transection, or distraction.  The most common injury 
mechanism in humans is impact plus persistent compression (Dumont et al., 
2001).  Tissue movement as a result of impact occurs predominantly at the 
center of the spinal cord, shearing cell membranes and severely injuring axons 
near the gray matter (GM).  The surface of the spinal cord experiences the least 
movement, allowing axons near the pia to survive and form a subpial axonal rim 
(Profyris et al., 2004).  Myelinated axons are also extremely vulnerable to 
stretching from tissue movement because the longitudinal forces are 
concentrated at nodes of Ranvier (Profyris et al., 2004).   
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The initial mechanical disruption of the spinal cord is followed by a progressive 
secondary injury cascade that destroys local and distant nervous tissue (Dumont 
et al., 2001; Norenberg, Smith, & Marcillo, 2004; Profyris et al., 2004).  These 
degenerative mechanisms can prevent the transmission of neural activity across 
the lesion, resulting in permanent sensory, motor, and autonomic 
dysfunction.  The secondary injury cascade consists of 3 overlapping phases: 
acute, sub-acute, and chronic.   
1.1.1 Acute Phase 
The acute phase occurs from seconds to the first few days after the injury.  It is 
characterized by vascular damage, cellular membrane damage, inflammation 
and aberrant release of neurotransmitters in the extracellular space (Ahn, Lee, & 
Kang, 2006; Bramlett & Dietrich, 2007; Dumont et al., 2001).  Vascular damage 
includes hemorrhage and edema, resulting in decreased blood flow and 
pressure-induced ischemia.  Excessive glutamate release causes excitotoxicity 
by activating NMDA and AMPA/kainite signaling, leading to apoptosis of neurons 
and oligodendrocytes (OLs) and the initiation of Wallerian degeneration (WD) 
and demyelination (McDonald, Althomsons, Hyrc, Choi, & Goldberg, 1998; 
McDonald, Shapiro, Silverstein, & Johnston, 1998; Profyris et al., 2004).  This 
first wave of apoptosis starts within a few hours post–injury (PI) and continues for 
several days in the lesion epicenter (Profyris et al., 2004).  Oligodendrocyte 
progenitor cells (OPCs), which go on to differentiate into mature myelinating OLs, 
migrate to the injury site and proliferate extensively to replace the lost OLs, 
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reaching peak numbers within 2 days after injury (Barnabé-Heider et al., 2010; 
Rabchevsky, Sullivan, & Scheff, 2007).  Microglia become activated, while 
leukocytes and macrophages invade and accumulate around the lesion epicenter 
(Bramlett & Dietrich, 2007; Norenberg et al., 2004). 
1.1.2 Sub-acute Phase 
The sub-acute phase, beginning a few days post-injury (DPI) and lasting for 
several weeks, includes revascularization, removal of necrotic debris, prominent 
glial responses, and a second wave of cell death.  An increase in the number of 
blood vessel returns blood flow to the injured tissue.   Activated microglia 
continue to secrete both protective (TNFα, IL-1β, IL-6) and harmful (glutamate, 
cytokines, nitric oxide, proteases, superoxide anions) molecules, while 
macrophages phagocytize debris from the first wave of necrosis and apoptosis 
(Norenberg et al., 2004).  A glial scar starts to form around the lesion epicenter, 
initially consisting of myelin debris, blood born macrophages, and microglia.  
Astrocytes become activated at the edge of the lesion, sending out longer and 
thicker processes that will eventually become part of the astroglial scar (Fawcett 
& Asher, 1999; Profyris et al., 2004; Yuan & He, 2013).  A second wave of 
apoptosis begins both rostral and caudal to the level of the lesion, occurring 
primarily in the WM, exacerbating axonal degeneration and demyelination 
(Bramlett & Dietrich, 2007; Profyris et al., 2004).  In contrast, decreased 
apoptotic cell death in the injury epicenter, combined with repopulation of OLs in 
spared WM tracts, results in diminished levels of primary demyelination by 7 DPI 
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(Rabchevsky et al., 2007; Totoiu & Keirstead, 2005).  The progressive increase 
in mature OLs during this time period is paralleled by a significant recovery of 
hind limb motor function in rat models of traumatic SCI, suggesting that 
remyelination of spared axons contributes to functional recovery.  However, 
newly formed myelin remains morphologically distinct from normal myelin, 
resulting in axons with lower G-ratios (the ratio of the thickness of the myelin 
sheath to the diameter of the axon) and increased distance between internodes 
(Griffiths & McCulloch, 1983), possibly limiting complete functional recovery. 
1.1.3 Chronic Phase 
In the weeks to months and years after traumatic SCI, a cyst forms in the lesion 
epicenter and replaces the injured spinal cord tissue.  Representing the final 
phase of the necrotic process, the fluid-filled cyst does not cause a problem 
clinically, but it is a poor substrate for axonal regeneration.  Both an astroglial 
and a mesenchymal scar surround the cyst, isolating it from spared tissue.  
Processes from activated astrocytes become tightly interwoven to form the 
astroglial scar, resulting in an impenetrable physical barrier to axonal 
regeneration in animal models of SCI (Fawcett & Asher, 1999; Karimi-
Abdolrezaee & Billakanti, 2012; Wanner et al., 2013; Yuan & He, 2013).  In 
contrast, astroglial scar formation is much milder in humans and acts as a 
molecular barrier by secreting growth-inhibitory molecules such as myelin-
associated glycoprotein (MAG), myelin oligodendroyte glycoprotein (MOG), 
chondroitin sulfate proteoglycan (CSPG), and Nogo (Fawcett & Asher, 1999; 
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Norenberg et al., 2004).  It is the mesenchymal scar, composed of collagen and 
fibrous connective tissue,that provides an impenetrable physical barrier to 
regenerating axons in SCI patients.    
Oligodendrocyte remyelination continues in the chronic phase, peaking at 10 
weeks after injury in adult rats (Totoiu & Keirstead, 2005).  Although newly 
formed myelin remains morphologically distinct from normal myelin, there is a 
significant positive correlation between remyelination and the recovery of function 
PI (Duncan, Brower, Kondo, Curlee, & Schultz, 2009).  Therefore, therapeutic 
interventions that augment and stabilize regenerative mechanisms such as 
remyelination could result in substantially improved outcomes after SCI.  
1.2 Current Strategies for Spinal Cord Repair 
1.2.1 Overview 
Numerous barriers must be overcome to restore function after CNS injury, 
including the replacement of lost tissue, scar removal, relief from inhibitory 
molecules, growth and guidance of regenerating axons, and remyelination of 
both spared and regenerated axons (Belegu, Oudega, Gary, & McDonald, 2007).  
Therapeutic interventions, such as cell transplantation (reviewed by J. Li and 
Lepski 2013), pharmacological intervention (reviewed by Wilson, Forgione, and 
Fehlings 2013; Bradbury and Carter 2011), biomaterials (reviewed by Krishna et 
al. 2013), epigenetic modulation (reviewed by Madathil et al. 2011; MacDonald 
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and Roskams 2009), activity-based therapies (Belegu et al., 2007), and 
functional electrical stimulation (Sadowsky et al., 2013) could attenuate 
secondary damage and augment regenerative mechanisms, resulting in 
substantially improved outcomes after SCI. 
1.2.2 Functional Electrical Stimulation 
Previous work has shown that electrical stimulation (ESTIM) of nerve tissue can 
improve activity-dependent processes.  ESTIM enhances myelination by OLs 
and Schwann cells (SCs), the myelinating cells of the peripheral nervous system 
(PNS), when they are co-cultured with dorsal root ganglia (Ishibashi et al., 2006; 
Malone et al., 2013; B Stevens, Tanner, & Fields, 1998).  OL survival is 
increased after stimulation of mixed cortical cultures (Gary et al. 2012).  
Unilateral stimulation of the medullary pyramid in adult rats promotes OPC 
proliferation and differentiation in the contralateral corticospinal tract (CST) (Q. Li, 
Brus-Ramer, Martin, & McDonald, 2010).  Improved axonal regeneration and 
remyelination are observed in the crush-injured sciatic nerves of adult rats after 
just one hour of ES (Wan, Xia, & Ding, 2010).  Additionally, short-term stimulation 
of the intact sciatic nerve in adult rats augments regeneration of its injured central 
projections into the lesion site after a chronic dorsal funiculotomy (Udina et al., 
2008).   
SCI results in decreased neural activity below the injury level, possibly limiting 
the spinal cord’s endogenous repair potential (Dietz, 2010, 2012; Edgerton et al., 
2001).  Functional electrical stimulation (FES) returns patterned neural activity to 
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the injured spinal cord by activating peripheral nerves and generating functional 
movement of extremities that are paralyzed as a result of nervous system injury. 
When used as a rehabilitative therapy, FES can ameliorate muscle atrophy 
(Griffin et al., 2009; Sadowsky et al., 2013), increase muscle strength (Davis, 
Hamzaid, & Fornusek, 2008; Johnston, Modlesky, Betz, & Lauer, 2011) and 
endurance (Davis et al., 2008), enhance aerobic metabolism (Hamzaid, Pithon, 
Smith, & Davis, 2012), lessen spasticity (Sadowsky et al., 2013), promote 
intralimb coordination (Field-Fote & Tepavac, 2002), and improve both sensory 
and motor function in patients with CNS injury (Griffin et al., 2009; Sadowsky et 
al., 2013).  In rodent models of SCI, FES treatment improves interlimb 
coordination (Jung, Belanger, Kanchiku, Fairchild, & Abbas, 2009), locomotion, 
and neurovascular response after an acute spinal cord contusion (Beaumont et 
al., 2013).  It also promotes proliferation of neural progenitors cells after chronic 
spinal cord transection (Becker, Gary, Rosenzweig, Grill, & McDonald, 2010).  
However, the cellular and molecular mechanisms underlying the beneficial 
effects of FES therapy are not fully understood. 
1.2.3 Epigenetic Modulation 
Cellular development in the CNS is regulated intrinsically by communication 
between transcription factors and epigenetic factors (MacDonald & Roskams, 
2009).  The epigenome, which includes microRNAs (miRs), DNA 
methyltransferases (DNMTs), and histone deacetylases (HDACs), controls gene 
expression without affecting DNA sequences, possibly in response to external 
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stimuli (Morrison, Rodgers, Morgan, & Bale, 2013).  Dsyregulation of the 
epigenome underlies aberrant CNS function in mental retardation, psychiatric 
disorders, and CNS injury (MacDonald & Roskams, 2009), making it a likely 
target for therapeutic intervention. 
1.2.3.1 microRNAs 
MicroRNAs (miRs) are small non-coding RNAs, approximately 23 nucleotides 
long, that base pair to the 3’ untranslated region (3’UTR) of protein-coding gene 
mRNA.  They control genes post-transcriptionally by inhibiting mRNA translation 
or targeting the mRNA for degradation (Dugas & Notterpek, 2011; He, Yu, 
Awatramani, & Lu, 2011).  A miR only needs to be partially complementary to the 
target messenger RNA, allowing for the regulation of multiple target genes 
simultaneously.  A specific network of miRs regulates gene expression in OL 
lineage cells during nervous system development (Barca-mayo & Lu, 2012).  
This network is dysregulated after CNS injury, possibly limiting endogenous 
regeneration and functional recovery (N.-K. Liu, Wang, Lu, & Xu, 2009; Yunta et 
al., 2012).   
CNS injury results in dysregulation of the miR network, particularly the one that 
controls OL biology.  In rodent models of acute SCI, these alterations are evident 
within and extending beyond the lesion epicenter (N.-K. Liu et al., 2009; 
Strickland et al., 2011; Yunta et al., 2012).  The vast majority of miRs are 
downregulated at 1 DPI, and continue to decrease for up to a week after injury 
(N.-K. Liu et al., 2009; Strickland et al., 2011; Yunta et al., 2012).  This trend is 
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also observed in OL-specific miRs, including miR-9, 138, 338*, 219-5p, and 219-
2-3p (N.-K. Liu et al., 2009; Yunta et al., 2012), possibly limiting the extent of 
endogenous remyelination after injury.  miR-17 and miR-20a of the 17-92 cluster 
are suppressed at the lesion site 3 days after a contusion injury, but return to 
control levels by 7 DPI (Yunta et al., 2012).  In contrast, miRs-17 and 92a are 
elevated at both 1 and 7 DPI (N.-K. Liu et al., 2009).  
microRNAs have also been implicated in the pathophysiology following traumatic 
brain injury (TBI), multiple sclerosis (MS), and ischemic stroke (Bhalala, Srikanth, 
& Kessler, 2013; J.-S. Li & Yao, 2012; N.-K. Liu & Xu, 2011; Madathil et al., 
2011).  TBI in adult rats results in the upregulation of miRs-199a, 17-5p, 20a, and 
23a*, while suppressing miRs-9, 19b, 138, and 338 (Z. Hu et al., 2012; Lei, Li, 
Chen, Yang, & Zhang, 2009).  Elevated levels of miR-92a were observed the in 
the plasma of mild and severe TBI patients, making it a potential biomarker for 
diagnosing TBI in humans (Redell, Moore, Ward, Hergenroeder, & Dash, 2010).  
Stroke elevates expression of the miR-17-92 cluster (Xian Shuang Liu et al., 
2013), while repressing miR-124a (Xian Shuang Liu et al., 2011) in the 
subventricular zone (SVZ) of adult mice.  It also downregulates miR-9 in ischemic 
white matter OPCs and OLs, leading to enhanced levels of serum response 
factor (SRF), a transcription factor that mediates OL differentiation (Buller et al., 
2012).  MS lesions, both active and inactive, have elevated levels of miR-214 
and miR-23a, possibly reflecting endogenous attempts at remyelination (Junker 
et al., 2009).  In contrast, miR-219 and miR-338 are heavily repressed in 
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chronically demyelinated lesions, which would limit the ability of OLs to 
differentiate and synthesize myelin (Junker et al., 2009). 
Several studies have observed enhanced cellular regeneration and functional 
recovery after CNS injury by altering miR expression patterns, suggesting the 
potential use of miRs as therapeutic tools.  The neuroprotective gene neurogenin 
1 (Ngn1), which increases neurogenesis and motor neuron survival after 
traumatic SCI, can be upregulated by the inhibition of miR-20a of the miR-17-92 
cluster (Jee, Jung, Im, Jung, & Kang, 2012).  Knockdown of miR-486 promotes 
functional motor recovery by enhancing the expression of proneural factor 
NeuroD6 (Jee, Jung, Choi, et al., 2012).  Systemic delivery of neural 
stem/progenitor cells (NSPCs) that overexpress miR-124 in contused rats 
enhances neuronal differentiation, at the expense of astroglial differentiation, 
decreases the lesion cavity volume, and stimulates functional recovery compared 
to control animals and those injected with normal NSPCs (Xu, Wang, Li, Qin, & 
Jiang, 2012).  miR-124 can also be used to prevent persistent hyperalgesia and 
mechanical allodynia (Willemen et al., 2012).  Infusion of miR-23b improves 
neuropathic pain in the injured spinal cord and restores GABA-mediated 
inhibitory mechanisms by preventing the death of GABAergic neurons (Im et al., 
2012).  Another potential therapeutic target is miR-21, which is upregulated over 
time following acute SCI (Bhalala et al., 2012; J.-Z. Hu et al., 2013).  Its 
overexpression in astrocytes suppresses their typical hypertrophic response to 
SCI, resulting in a glial scar that’s more permissive to axonal regeneration into 
the lesion site (Bhalala et al., 2012).  Global inhibition of miR-21 after SCI is 
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detrimental to the recovery of hindlimb motor function, tissue sparing, and lesion 
size (J.-Z. Hu et al., 2013), illustrating the need to modulate miR expression in a 
cell-specific manner after CNS injury to maximize protective and regenerative 
mechanisms. 
Exercise can also be used to modulate miR activity in the injured spinal cord.  
Following a complete spinal cord transection at vertebral level T10, five days of 
passive hind limb cycling per week increases miR-21 expression in the lumbar 
spinal cord, resulting in suppressed PTEN signaling (G. Liu, Detloff, Miller, Santi, 
& Houlé, 2012; G. Liu, Keeler, Zhukareva, & Houlé, 2010).   In contrast, exercise 
blocks expression of miR-15b and miR-199a-3p, causing enhanced mTOR and 
Bcl-2 signaling, respectively.  Cycling exercise also ameliorates the injury-
induced increase in caspase-7 and -9 mRNA levels (G. Liu et al., 2010).  Taken 
together, these finding suggest that activity-dependent changes in miR 
expression can promote axonal regeneration and neuronal plasticity, as well as 
hinder apoptotic cell death, in the injured spinal cord. 
1.2.3.2 DNA Methylation 
DNMTs catalyze the addition of methyl groups to cytosine residues in DNA, 
almost exclusively within cytosine-phosphate-guanine (CpG) rich domains 
(reviewed by MacDonald and Roskams 2009).  Methyl-CpG-binding domain 
(MBD) proteins then bind to the methylated DNA, ultimately resulting in 
suppression of gene transcription. DNA methylation enzymes can be divided into 
2 classes, maintenance (DNMT1) and de novo DNMTs (DNMT3a, DNMT3b).  
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Maintenance DNMTs preserve methylation patterns in daughter cells by adding 
methyl groups to partially-methylated CpGs during DNA replication, while de 
novo DNMTs create new methylation patterns by adding methyl groups to 
unmethylated CpGs.  Expression of all 3 DNMTs can be found throughout the 
postnatal and adult CNS (Simmons, Stringfellow, Glover, Wagle, & Clinton, 
2013), and they are required for normal CNS development (MacDonald & 
Roskams, 2009).   
The effect of SCI on DNA methylation is not fully understood.  However, the 
changes in DNMT activity observed after other types of CNS injury and disease 
suggests that DNMTs may be involved in the pathophysiology observed after 
traumatic SCI.  Alterations in DNA methylation have been implicated in TBI, 
ischemic stroke, amyotrophic lateral sclerosis (ALS), and schizophrenia.  
Traumatic brain injury in adult rats decreases global DNA methylation both within 
and adjacent to the lesion site during the first 48 hours after injury, with microglia 
and macrophages being the major source of hypomethylated cells (Z.-Y. Zhang, 
Zhang, Fauser, & Schluesener, 2007).  DNMT1, which is predominantly 
expressed in the nucleus of proliferating cells and the cytoplasm of mature 
neurons, is upregulated in the nucleus and cytoplasm of astrocytes after TBI, 
suggesting that DNA methylation plays a role in the astrocytic response to CNS 
injury (Lundberg et al., 2009).  The maintenance DNMT is associated with the 
delayed death of hippocampal neurons after transient cerebral ischemia in 
gerbils (Lee et al., 2013), and the complete elimination or reduction of DNMT1 in 
post-mitotic neurons confers resistance to ischemia-induced TBI (MacDonald & 
 13 
Roskams, 2009).  The gene for the glial-specific potassium channel Kir4.1 is 
methylated by DNMT1, resulting in decreased Kir4.1 expression in epilepsy, 
ALS, ischemic brain injury, and SCI (Nwaobi, Lin, Peramsetty, & Olsen, 2014).  
Aberrant levels of DNMT3a also underlie the elevated motor neuron 
degeneration observed in human ALS patients (Martin & Wong, 2013).  
Increased methylation of the Sox10 gene, a mediator of terminal OL 
differentiation, represses OL gene expression in patients suffering from 
schizophrenia (Iwamoto et al., 2005).   
To our knowledge, only one study has investigated to role of DNMTs in SCI 
repair (Iskandar et al., 2010).  The authors used a spinal cord regeneration 
model (SCRM) in which adult mice received a combined bilateral dorsal column 
transection SCI and a unilateral sciatic nerve conditioning lesion.  This injury 
model suppressed the expression of both de novo DNMTs and decreased overall 
spinal cord methylation.  Folic acid treatment eliminated the injury-induced 
dysregulation of DNMT3a and DNMT3b, thereby restoring spinal cord 
methylation to pre-injury levels and promoting regeneration of sensory axons 
(Iskandar et al., 2010).  Inhibiting DNMT3a activity protects motor neurons from 
apoptosis in vitro and in a mouse model of ALS (Martin & Wong, 2013). 
1.2.3.3 Histone Modification 
Acetylation of lysine residues in the N-terminal tails of histone proteins modulates 
the ability of histones to interact with DNA (reviewed by MacDonald and 
Roskams 2009).  Gene expression is promoted by hyperacetylation, which is 
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catalyzed by histone acetylases (HATs), and repressed by hypoacetylation, 
catalyzed by HDACs. Proteins with HDAC activity can be broken up into several 
classes: class I (HDAC1, 2, 3, and 8), class II (HDAC4, 5, 6, 7, 9, 10), class III 
(SIRT2 and sirtuin), and class IV (HDAC11) (MacDonald & Roskams, 2009).  
Acetylation homeostasis, which is maintained by a balance of HAT and HDAC 
activity, is dysregulated in SCI, ischemia, TBI, and demyelinating diseases, 
resulting in the global suppression of histone acetylation and neurological deficits 
(Shein & Shohami, 2011).  Administration of HDAC inhibitors after CNS injury 
can limit cell death and degeneration, as well as promote functional recovery, by 
restoring the HDAC-HAT balance, suggesting that HDACs are a potential 
therapeutic target for spinal cord repair.   
Reduced histone acetylation is observed within 24 hours after traumatic SCI in 
adult rats, continuing for up to 2 weeks post-injury (Lv et al., 2011).  Treatment 
with the HDAC inhibitor valproic acid (VPA) immediately or 8 hours after injury 
has a neuroprotective effect, decreasing lesion volume and preventing apoptotic 
cell death by upregulating the neuroprotective genes heat shock protein (Hsp70), 
B-cell lymphoma 2 (Bcl-2), brain-derived (BDNF) and glial-derived neurotrophic 
factor (GDNF), resulting in accelerated functional recovery (Lv et al., 2011; Lv, 
Han, Sun, Wang, & Dong, 2012).  Intraspinal delivery of VPA also reduces the 
injury-induced inflammatory response by downregulating expression of the 
purinergic receptor P2X4 in activated microglia (Lu et al., 2013).   
In rodent models of ischemic stroke, HDAC1/2 levels decline drastically in the 
lesion core, but are upregulated in astrocytes located in the adjacent subcortical 
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white matter (SCWM) (Baltan, Bachleda, Morrison, & Murphy, 2011).  Increased 
HDAC1 expression is also found in adjacent striatal neurons, while HDAC2 is 
elevated in the cortex, SCWM, and subventricular zone.  Treatment with VPA 
within 24 hours of a mild middle cerebral artery occlusion (MCAO) in rats 
promotes OL survival, oligodendrogenesis, and neurogenesis up to 1 month after 
injury (X S Liu et al., 2012).  Repression of HDAC activity with suberoylanilide 
hydroxamic acid (SAHA) stabilizes ATP levels and reduces glutamate-mediated 
excitotoxicity when administered before or after oxygen and glucose deprivation 
(OGD) in optic nerves isolated from adult mice, preserving white matter function 
and axonal recovery (Baltan, Murphy, Danilov, Bachleda, & Morrison, 2011).  
Hypoacetylation after TBI is associated with the robust activation of inflammatory 
microglia in the injured hippocampus, which can attenuated by systemic delivery 
of the benzamide class of HDAC inhibitors (Shein & Shohami, 2011; B. Zhang et 
al., 2008).  Treatment with VPA enhances motor function and spatial memory by 
reducing lesion volume, decreasing neuronal damage, and improving the 
integrity of the blood brain barrier (BBB) (Dash et al., 2010).   
Acetylation homeostasis plays a critical role in CNS white matter injury and 
repair.  Endoplasmic reticulum (ER) stress after contusive SCI causes the 
accumulation of the pro-apoptotic factor CHOP, resulting in axonal degeneration 
and demyelination (Penas et al., 2011).  Application of VPA decreases CHOP 
expression, thereby increasing OL survival and promoting locomotor recovery.  
Treatment with VPA prior to or after the induction of experimental autoimmune 
encephalomyelin (EAE) in adult rats promotes remyelination by recruiting NSPCs 
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and OPCs to the lesion site (Pazhoohan et al., 2014).  Inactivation of the Nbn 
gene, which underlies Nijmegen breakage syndrome, induces HDAC1/2 
suppression in callosal OPCs, causing increased OPC apoptosis and a severe 
myelination deficiency (B. Liu, Chen, Wang, & Tong, 2014). 
Following cuprizone-induced demyelination in the corpus callosum of 8 week old 
mice, HDAC1 is recruited to the promoter regions of the transcription factors 
Sox2 and Hes5 in OPCs (Shen, Sandoval, et al., 2008).  The HDAC-mediated 
suppression of these OL differentiation inhibitors precedes the upregulation of 
Olig1, a transcription factor that is critical for remyelination, and the myelin 
proteins CNP and MAG, resulting in spontaneous remyelination.  However, there 
is an age-dependent decline in HDAC recruitment after injury, which allows 
transcriptional inhibitors to accumulate in OL lineage cells and thereby limits the 
extent of spontaneous remyelination.  This epigenetic memory loss can be 
recapitulated by the administration of the HDAC inhibitor valproic acid (VPA) 
during cuprizone treatment in young mice or in cultures of differentiating OPCs.   
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Chapter 2: Extrinsic and Intrinsic 
Control of Oligodendrocyte Biology 
The oligodendrogenic developmental program is regulated by both extrinsic and 
intrinsic mechanisms.  Transcription factors, chromatin remodeling, DNA 
methylation, and miRs control oligodendrocyte (OL) biology intrinsically (Zuchero 
& Barres, 2013).  They play a role in every phase of OL biology, and often work 
together to regulate the various steps in OL development.  Extrinsic activity-
dependent communication between neurons and glia is also crucial in regulating 
oligodendrocyte progenitor cell (OPC) proliferation, OL differentiation, and myelin 
synthesis.  Previous work has demonstrated that neuronal activity can act on 
oligodendroglial cells both directly, through OL-axon synapses, and indirectly via 
soluble molecules released from axons and neighboring astrocytes. 
2.1 Origin and Lineage Specification 
2.1.1 Extrinsic Control 
During CNS development, neuroepithelial cells in the neural tube give rise to 
motor neurons, glia, and interneurons (Figure 2.1).  Motor neurons (MNs) are 
generated in the ventral progenitor domain (pMN), and their production is 
complete by embryonic day 10.5 (E10.5) in mice (Fancy, Chan, Baranzini, 
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Franklin, & Rowitch, 2011).  Beginning around E12.5, the floor and roof plates of 
the neural tube secrete the morphogens sonic hedgehog (SHH) and bone 
morphogenetic proteins (BMPs), respectively, triggering the switch from neuronal 
lineage specification to the generation of glial-restricted progenitors referred to as 
oligodendrocyte-type 2 astrocyte (O-2A) cells.  SHH signaling upregulates the 
transcription factors (TFs) Olig1/2 and Nkx6, promoting the first wave of OPC 
specification in the pMN and V0-V3 domains of the ventral neural tube (Mitew et 
al., 2013).  BMP signaling has the opposite effect, strongly inducing astroglial 
differentiation at the expense of oligdodendroglial fate by suppressing Olig1/2 via 
inhibitors of DNA binding (Id2/4) and the canonical Wnt/β-cantenin pathway 
(Rivera et al., 2010).  A second wave of OPCs, independent of SHH signaling 
and Nkx6, arises from the dorsal neural tube starting at E15.5 (Cai et al., 2005; 
Fogarty, Richardson, & Kessaris, 2005).  Dorsally-derived OPCs instead depend 
on fibroblast growth factor (FGF) to induce Olig-mediated lineage specification. 
OL lineage specification in the developing spinal cord also depends on the 
secretion of platelet-derived growth factor (PDGF), which promotes Olig2 
expression by activating the PDGF receptor α (PDFGRα) (Rivera et al., 2010).  
Despite their embryonic origins, both groups of OPCs have the same electrical 
properties (Tripathi et al., 2011), and together these cells will mature to form the 
majority of OL lineage cells in the spinal cord (Fu et al., 2002). 
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2.1.2 Intrinsic Control 
Intrinsic regulation of OL lineage specification occurs via epigenetic-mediated 
suppression of neural stem/progenitor cells (NSPCs) proliferation and alternative 
cell lineage progression (Figure 2.1).  Neural progenitors are maintained in an 
undifferentiated state by BAF53a, a subunit of the Swi-Snf-like neural progenitor-
specific BAF complex, and the transcription factor Sox2 (Shen & Casaccia-
Bonnefil, 2008; Yoo, Staahl, Chen, & Crabtree, 2009).  microRNAs-9/9* and -124 
promote the transition of proliferating NSPCs into post-mitotic cells by repressing 
of BAF53a in an activity-dependent process (Yoo et al., 2009).  Overexpression 
of these in cultures of mouse embryonic stem cells inhibits signal transducer and 
activator of transcription (STAT) 3 signaling, leading to reduced astrocyte lineage 
specification (Krichevsky, Sonntag, Isacson, & Kosik, 2006).  miR-124 also 
relieves inhibition of neuronal lineage progression by suppressing Sox9 (Cheng, 
Pastrana, Tavazoie, & Doetsch, 2009; Farrell, Power, & McDermott, 2011), 
REST/Scp1 (F. Ji, Lv, & Jiao, 2013; Visvanathan, Lee, Lee, Lee, & Lee, 2007), 
and Ptbp1 (Makeyev, Zhang, Carrasco, & Maniatis, 2007).  The proneural factors 
Isl1, NeuroD1, Otx2, FoxJ3 and ZFP238, which stimulate NSPC differentiation 
into neurons, are blocked by OL-specific miRs-219 and -338 (Dugas et al., 2010; 
Zhao et al., 2010). 
Histone deacetylation plays a major role in OL lineage specification. Addition of 
SHH to primary cultures of P1 rat cortical OPCs promotes HDAC1/2 activity, 
favoring OL lineage progression at the expense of astrogenesis (M. Wu et al., 
2012).  Both histone deacetylases prevent the binding of β-cantenin to the Wnt 
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pathway mediator TCF7L2, thereby relieving inhibition of Olig1/2 expression (Ye 
et al., 2009).  Blocking HDAC activity in cultured OPCs with trichostatin A (TSA), 
a class I HDAC inhibitor, promotes their conversion into NSPC-like cells that can 
give rise to all 3 CNS lineages (Lyssiotis et al., 2007).  This lineage reversion 
requires acetylation of the promoter region of Sox2, a TF responsible for 
maintaining NSPCs in an undifferentiated state, in addition to signaling by FGF.  
In contrast, addition of TSA to embryonic NSPC cultures induces neuronal 
differentiation and suppresses astrocyte differentiation without affecting 
oligodendrogenesis (Balasubramaniyan et al., 2006; Huiling Liu et al., 2012).  
Oligodendrocyte lineage specification in the developing rodent forebrain is 
delayed by postnatal treatment with the HDAC inhibitor valproic acid (VPA) 
(Shen, Li, & Casaccia-Bonnefil, 2005).  Valproic acid-mediated inhibition of 
HDAC activity in adult hippocampal NSPCs has a similar effect, inducing 
neurogenesis at the expense of oligodendrogenesis and astroglialgenesis by 
upregulating the expression of the transcription factor NeuroD (Hsieh, 
Nakashima, Kuwabara, Mejia, & Gage, 2004).   
The function of DNA methylation in the differentiation of NSPCs into OL lineage 
cells has yet to be determined.  However, DNMT activity is critical to the 
developmental switch from neurogenesis to astrogliogenesis (Juliandi, 
Abematsu, & Nakashima, 2010).  The maintenance DNA methyltransferase, 
DNMT1, is upregulated in the nucleus of replicating cells in the developing CNS 
(MacDonald & Roskams, 2009).  Expression of DNMT1 in NSPCs induces 
hypermethylation of the promoter for glial fibrillary acidic protein (GFAP), a gene 
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critical for astrocyte differentiation, preventing STAT3/SMAD binding and 
inhibiting the JAK/STAT signaling pathway (Fan et al., 2005).  Conditional 
deletion of DNMT1 in NSPCs shifts neural development toward astrogliogenesis.  
The de novo DNA methyltransferases, DNMT3a and 3b, are also required for 
neurogenesis.  Upregulation of DNMT3a/3b levels with folic acid induces 
neuronal lineage specification in neurospheres derived from neonatal rat NSPCs 
(Luo et al., 2013).  In addition, the ablation of DNMT3a in cultures of mouse 
embryonic stem cells results in enhanced NPSC proliferation, as well as 
precocious NPSC differentiation into astrocytes and OLs (Z. Wu et al., 2012).   
2.2 OPC Proliferation and Migration 
Following OL lineage specification, spinal cord OPCs continue to proliferate as 
they migrate substantial distances from their sites of origin.  The majority of 
ventral OPCs spread both dorsally and laterally and traverse several levels 
rostral and caudal to their originating level.  In contrast, OPCs that are dorsal in 
origin migrate to form more than 50% of OLs in the dorsal and lateral regions of 
the spinal cord (Fogarty et al., 2005).  As they migrate, OPCs continually extend 
their processes, using growth cones at the end of motile filopodia to survey the 
local environment (Simpson & Armstrong, 1999).  They are guided to their final 
site of myelination by environmental factors such as secreted motogenic 
molecules, adhesion molecules, and chemotactic cues.   
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2.2.1 Extrinsic Control 
Platelet-derived growth factor is the most important mitogen for maintaining the 
proliferative state of OPCs in spinal cord WM (Hill, Patel, Medved, Reiss, & 
Nishiyama, 2013), and is also a key motogenic factor regulating long-range OPC 
migration (de Castro & Bribián, 2005; Simpson & Armstrong, 1999).  The 
secreted factor activates the PDFGRα receptor on OPCs, stimulating the 
phosphatidylinositol 3-kinase (PI3K), phospholipase C gamma (PLCγ), and alpha 
6 beta 3 (α6β3) integrin signaling pathways (Baron, Shattil, & ffrench-Constant, 
2002; McKinnon, Waldron, & Kiel, 2005).  Fibroblast growth factor-2 (FGF2) 
signaling also plays an important role in OPC proliferation (Figure 2.2) and 
migration by upregulating expression of Olig2 and PDFGRα (Bansal & Pfeiffer, 
1997; Fortin, Rom, Sun, Yayon, & Bansal, 2005).  Both PDGF and FGF-2 induce 
rapid OPC division and regulate OPC migration while preventing lineage 
progression to the immature OL stage (de Castro & Bribián, 2005; Wolswjk & 
Noble, 1992).  
Loss of neural activity in the developing optic nerve (ON), via transection or 
injection of tetrodotoxin (TTX), suppresses OPC proliferation (Barres & Raff, 
1993) and reduces the number of myelinating OLs (Demerens et al., 1996).  
NG2+ OPCs receive synaptic input from axon collaterals in several CNS regions, 
including the hippocampus, dentate gyrus, corpus callosum, and cerebellum 
(Bergles, Jabs, & Steinhäuser, 2010). This synaptic input is maintained while 
OPCs proliferate and migrate, but disappears as they differentiate into immature 
OLs, suggesting a role for direct synaptic input in the development of 
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oligodendroglial cells (De Biase, Nishiyama, & Bergles, 2010; Kukley et al., 2008; 
Kukley, Nishiyama, & Dietrich, 2010).  NG2+ OPCs express voltage-gated Na 
(NaV) channels, along with ionotropic glutamate and GABA receptors, and 
glutamatergic signaling between neurons and OL lineage cells has been 
implicated in promoting OL differentiation (De Biase et al., 2010).   
2.2.2 Intrinsic Control 
The miR-17-92 cluster, along with miRs-9, -214, and -199a-5p and DNMT1, 
regulates OPC proliferation (Figure 2.2).  The gene for the miR-17-92 cluster 
encodes 12 distinct mature products, 6 of which have been implicated in OPC 
proliferation: miRs-17, 18a, 19a, 20a, 19b, 92a (Budde et al., 2010; De Faria Jr et 
al., 2012).  This cluster, found in the CNS white matter of humans and rodents 
(De Faria Jr et al., 2012), is one of most abundant miR families in both OPCs and 
mature OLs (Budde et al., 2010).  microRNA-19b promotes the differentiation of 
NSPCs into OPCs (Figure 2.1), and keeps OPCs in their proliferative state 
(Figure 2.2), by inhibiting the tumor suppressor Pten and activating the 
PI3K/Akt/mTOR pathway (Budde et al., 2010).  Oligodendrocyte differentiation is 
prevented by miR-20a, which suppresses PLP/DM20 levels (Wang & Cambi, 
2012).   Oligodendrocyte progenitor cells have high levels of miR-9 and miR-214, 
which increase OPC numbers by targeting serum response factor (SRF), a 
transcription factor, and the myelin proteins PMP22 and Mobp (Buller et al., 
2012; Lau et al., 2008; Letzen et al., 2010).  The transcription factor E2F1, 
expressed in OL lineage cells, binds to UHRF1 and increases DMNT1 activity 
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and specificity, thereby preventing OPCs from exiting the cell cycle (Bashtrykov, 
Jankevicius, Jurkowska, Ragozin, & Jeltsch, 2013; Magri et al., 2014). 
2.3 OPC Differentiation 
An intrinsic “clock”, along with extracellular signals, regulates the fates of 
proliferating OPCs as they exit the cell cycle and differentiate into post-mitotic, 
premyelinating OLs.  This transition is induced in vitro by mitogen withdrawal 
and/or the presence of triiodothyronine/thyroid hormone 3 (T3), although T3 is 
not essential for OPC differentiation (Barres et al., 1994; Gao et al., 1997; 
Durand and Raff, 2000).  Initial OPC differentiation is characterized by the 
expression of proteolipid protein (PLP), myelin basic protein (MBP), and 2’-3’-
cyclic nucleotide 3’-phosphohydrolase (CNP) (Pfeiffer, Warrington, & Bansal, 
1993).  These immature OLs send out numerous processes to survey the local 
environment and find the correct axons to myelinate.  This stage is transient in 
rodents, where OLs that fail to make an axonal connection during development 
undergo programmed cell death (Trapp, Nishiyama, Cheng, & Macklin, 1997). 
Rodent OLs have ~12 hours to select axons for myelination in vitro, regardless of 
the final number of sheaths that are made (Czopka, Ffrench-Constant, & Lyons, 
2013; Watkins, Emery, Mulinyawe, & Barres, 2008).  In contrast, premyelinating 
OLs in the developing human brain have several months to fine tune their axonal 
selection (Back, Luo, Borenstein, Volpe, & Kinney, 2002). 
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2.3.1 Extrinsic Control 
Propagating action potentials cause axons to release ATP, which binds directly 
to astrocytes or is hydrolyzed to adenosine by ectoenzymes.  ATP signaling 
leads to the liberation of leukemia inhibitory factor (LIF) from astrocytes (Cohen & 
Fields, 2008), which stimulates OL maturation and myelination (Ishibashi et al 
2006).  Ablation of LIF signaling results in delayed OL differentiation in the 
developing mouse optic nerve at P10, but the myelination defect recovers by 
P14, suggesting that LIF is required for the onset, but not the completion, of CNS 
myelination during development (Ishibashi, Lee, Baba, & Fields, 2009).  
Adenosine inhibits OPC proliferation, instead promoting differentiation and myelin 
formation by activating purinergic receptors (Stevens 2002).  
2.3.2 Intrinsic Control 
microRNAs-219, 138, and 338 are also major regulators of OL differentiation.  
Enriched in white matter of the adult human brain (De Faria Jr et al., 2012) and 
postnatal rodent spinal cord (Zhao et al., 2010), these miRs are considered OL-
specific because their expression is much higher in OLs relative to both 
astrocytes and neurons (Dugas et al., 2010).  All three are induced by mitogen 
withdrawal in primary OPC cultures, but not by exposure to T3 (Dugas et al., 
2010).  Peak expression of miR-219 and miR-338 coincides with the onset of OL 
maturation in the mouse spinal cord at P20 (Zhao et al., 2010).   Together they 
promote OL differentiation by suppressing the expression of PDGFRα, FGFR2, 
Sox6, and Hes5, which function to keep OPCs in an undifferentiated state 
 26 
(Dugas et al., 2010; Zhao et al., 2010).  microRNA-219 is the most abundant miR 
in mature A2B5−GalC+ rat OLs (Lau et al., 2008), and it is is a key regulator of 
rapid OL differentiation that’s induced by mitogen withdrawal (Dugas et al., 
2010).  microRNA-138 is more weakly expressed in rodent CNS white matter and 
has opposing effects on OL differentiation, promoting the early phase (CNP, 
MBP) while delaying the later phase (MOG) (Dugas et al., 2010).   
Histone deacetylase activity is also required for OL maturation (Figure 2.2).  
HDAC1/2 downregulate Sox2 expression in OPCs, inducing their differentiation 
into mature OLs (Shen, Liu, Li, Wolubah, & Casaccia-Bonnefil, 2008).  They also 
outcompete β-catenin for interaction with the transcription factor TCF7L2 during 
development, and disruption of HDAC1/2 is severely detrimental to OL 
differentiation (Ye et al., 2009).  Sirtuin2 (SIRT2), an OL-specific HDAC, 
promotes OL differentiation through enhanced MBP expression in the OPC cell 
line CG4 (S. Ji, Doucette, & Nazarali, 2011).  This process is inhibited by Nkx2.2, 
which recruits HDAC1 to the SIRT2 promoter and negatively regulates its 
expression.  Expression of SIRT2 in the developing CNS is also correlated with 
that of CNP, where it is found in OL processes and the myelin sheath (Shen & 
Casaccia-Bonnefil, 2008).  Recruitment of HDAC11 to the genes for MBP and 
PLP correlates with their increased expression in maturing OL-1 cells, a 
nontransformed rat OL cell line (Hedi Liu, Hu, D’ercole, & Ye, 2009).  Valproic 
acid-induced HDAC inhibition during the first 10 postnatal days impedes OL 
differentiation in the developing rat corpus callosum, resulting in significant 
hypomyelination and delayed expression of myelin proteins (Shen et al., 2005).  
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In contrast, HDAC inhibition does not effect OL maturation or myelination when 
VPA treatment occurs after the 3rd postnatal week, when differentiation is almost 
complete, suggesting that HDAC activity is critical for the initial stages of OPC 
differentiation into postmitotic OLs. 
To our knowledge, DNMT-mediated regulation of OL lineage progression has not 
been established.  However, methylation of the Sox10 gene, a TF required for 
terminal OL differentiation, is correlated with its reduced expression and the 
repression of other OL-related genes in patients suffering from schizophrenia 
(Iwamoto et al., 2005), suggesting that DNMT activity may be involved in the 
regulation of OL development. 
2.4 Myelination 
Following differentiation and axonal selection, OLs continually extend and retract 
their processes until a process starts to spiral around an adjacent axon in a cork-
screw like manner, resulting in a multiple layers of cell membrane (Ioannidou, 
Anderson, Strachan, Edgar, & Barnett, 2012).  Cytoplasm is extruded and the 
membrane stack is compacted to form functional myelin.  Each OL can generate 
up to 50 internodes during development (Pfeiffer et al., 1993).  However, the 
number and length of internodes depends on the animal’s age at the time of 
myelin synthesis (Young et al., 2013). 
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2.4.1 Extrinsic Control 
Neural activity induces the vesicular release of glutamate from axons (Wake, 
Lee, & Fields, 2011), which triggers signaling cascades by activating NMDA and 
AMPA receptors on oligodendroglial cells.  While both receptors are responsible 
for activity-dependent inward Ca2+ currents, they play different roles in the 
oligodendrogenic developmental program (De Biase et al., 2011).  AMPA 
receptor (AMPAR) signaling activates the Fyn kinase pathway, enhancing local 
MBP synthesis in OLs (Wake et al., 2011).  Instead of regulating OL 
development, NMDA receptor (NMDAR) signaling is used to control the 
expression of Ca2+-permeable AMPA receptors on OL lineage cells.  OPCs 
lacking the NMDAR subunit R1, which is required for normal NMDAR signaling, 
are able to proliferate, differentiate, myelinate major WM tracts, and form 
glutamatergic synapses normally (De Biase et al., 2011).   
2.4.2 Intrinsic Control 
Known epigenetic regulators of terminal OL maturation and myelin protein 
synthesis includes miR-219, miR-23a, miR-214, and the miR-17-92 cluster.  
microRNA-219 influences lipid accumulation by inhibiting the protein ELOLV7 
(Shin, Shin, McManus, Ptácek, & Fu, 2009), whereas miR-20a of the miR-17-92 
cluster inhibits myelination by suppressing expression of the myelin proteins 
PLP/DM20 (Wang & Cambi, 2012).  Using transgenic mice that express miR-23a 
under control of the CNP promoter, Lin et al. (2013) observed that miR-23a 
overexpression stimulates hypermyelination in the corpus callosum by increasing 
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myelin thickness and promoting proper myelin folding.  Excess miR-23a induces 
both OPC differentiation (MBP, PLP) and myelin synthesis (MAG, MOG) through 
two separate mechanisms: suppression of lamin B1 levels and activation of the 
Akt/mTOR pathway (S.-T. Lin & Fu, 2009; S. Lin et al., 2013).  Demethylation of 
the MAG gene is associated with OL maturation and myelin synthesis in vitro 
(Grubinska, Laszkiewicz, Royland, Wiggins, & Konat, 1994).  Similar 
demethylation patterns may occur with other coordinately expressed myelin-




Figure 2.1. Epigenetic regulation of CNS cell lineage specification. 
Epigenetic factors such as miRs, HDACs, and DNMTs influence signaling 
pathways in NSPCs, resulting in the inhibition (red) or promotion (green) of 




Figure 2.2. Epigenetic control of OL lineage progression. 
Epigenetic factors inhibit (red) or promote (green) expression of their target 





Chapter 3: Functional Electrical 
Stimulation after Chronic Spinal 
Cord Injury in Adult Rats 
3.1 Chapter Overview 
Our lab has developed a rodent model of functional electrical stimulation (FES) 
that alternately stimulates the large myelinated fibers of the common peroneal 
nerves in the tibialis anterior muscles.  This model produces a crude 
approximation of hind limb bilateral stepping and, thereby, returns patterned 
neural activity that is typically diminished below the lesion level after a spinal cord 
injury (SCI).  Using this model, Becker et al. found that applying FES after a 
chronic thoracic transection injury in adult rats enhances the proliferative 
response of neural precursor cells in a region of the lumbar spinal cord (Becker 
et al., 2010) that is associated with the central pattern generator (CPG) for 
locomotion (Edgerton et al., 2001).  However, that study only utilized a single 
frequency (20 Hz), and several studies have shown that the extent of 
oligodendrocyte (OL) survival, myelination, and axonal regeneration after 
electrical stimulation depends on the stimulation frequency (Gary et al., 2012; 
Malone et al., 2013; Udina et al., 2008).  The purpose of this study was to 
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determine if FES treatment influences the proliferation of cells in the OL lineage 
after a chronic complete thoracic SCI in adult rats, and if these changes are 
frequency dependent.   
3.2 Methods 
3.2.1 Experimental Design 
Adult female Long Evans rats (200-250 g upon arrival; Harlan) received a 
complete transection at vertebral level T9.  FES treatment began 1 month post-
injury (PI), and continued for 3 weeks (Figure 3.2).  Bromodeoxyuridine (BrdU) 
(50 mg/kg i.p.), a thymidine analogue that is incorporated into replicating DNA, 
was injected daily during the last 5 days of stimulation to identify dividing cells.  
The experimental groups (n = 10 per group) were: 
1) Control, no FES 
2) FES at 2 Hz 
3) FES at 20 Hz 
4) FES at 100 Hz 
3.2.2 Animal Care 
Animals were anesthetized with an intraperitoneal (IP) injection of dexdomitor 
(0.4 mg/kg; Pfizer Animal Health 6295) and ketathesia (60 mg/kg; Butler Schein 
Animal Health 043012).  Controlled heating pads maintained animal body 
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temperature during surgery and the recovery period.  Anesthesia was reversed 
with an intramuscular injection (IM) of 0.05 ml antisedan (1 mg/kg; Pfizer Animal 
Health 6298).  Daily injections of Lactated Ringer’s solution (10 ml; Henry Schein 
1002435) and 0.03 ml of gentamycin (40 mg/ml; Henry Schein 1049944) were 
given subcutaneously and IM, respectively, for up to a week after surgery.  
Bladders were expressed twice daily for the duration of the experiment. 
3.2.3 Spinal Cord Injury 
A midline incision was made in the upper back, and the overlying musculature 
was dissected to reveal the dorsal and lateral processes of the spinal column.  A 
dorsal laminectomy at vertebral level T9 exposed the spinal cord, and a small slit 
was made in the dura using a 20G needle (Becton Dickinson 305175).  A metal 
canula, attached to a vacuum pump (Bio-rad), applied 20 in Hg of suction to 
remove approximately 3 mm of spinal cord tissue through the dural slit, thereby 
completely transecting the spinal cord.  This suction ablation injury model 
minimizes damage to the dura while eliminating all ascending and descending 
neural activity across the lesion, allowing us to determine both the local and 
global effects of FES.  After the injury, the overlying musculature was sutured 
together and the skin incision closed with surgical staples.  Animals were allowed 
to recover overnight in heated cages, with food and water ad libitum, and then 
housed in unheated cages for the duration of the experiment. 
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3.2.4 Electrode Implantation 
The FES implant (Figure 3.1) consisted of a plastic pedestal connected to 3 
stainless steel electrode pads (1 mm x 0.6 mm x 3.18 mm) with nylon-coated 
stainless steel wires (PlasticsOne MS333/76H).  The pedestal was secured in a 
harness (Instech CIH95AB) around the animal’s upper torso, while an incision in 
the skin of the upper back allowed the electrode leads to be tunneled 
subcutaneously.  A stimulating electrode pad was sutured into the tibialis anterior 
muscle of each hind limb, adjacent to the common peroneal nerve, and the 
ground electrode was sutured to the musculature of the lower back near the 
midline.  All animals were fitted with plastic collars after electrode implantation to 
prevent autophagia and housed in separate cages.  FES treatment began 3 days 
after electrode implantation. 
3.2.5 Functional Electrical Stimulation 
A two-channel swivel commutator (PlasticsOne SL2C) was secured to the inside 
of each cage lid and connected to the electrode pedestal with a spring-covered 
bipolar cable (PlasticsOne) during FES.  An external stimulator was connected to 
the commutators to provide stimulation.  Animals were disconnected from the 
commutators daily after the cessation of treatment.  Action potentials were 
induced using biphasic pulses (3 mA, 200 µs) for 1 hour, 3 times per day, at 
varying frequencies.  The stimulation pattern was: 1 s stimulation of one common 
peroneal nerve, then 1 s of rest, followed by 1 s stimulation of the other common 
peroneal nerve, and 1 s of rest.  These stimulation parameters preferentially 
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activate the large myelinated fibers of the common peroneal nerve (Gorman & 
Mortimer, 1983; Grill & Mortimer, 1996), which is expected to increase afferent 
activity in the lumbar spinal cord (Rivero-Melián, 1996; Swett & Woolf, 1985).  All 
animals underwent SCI and electrode implantation, but control animals did not 
receive FES treatment. 
3.2.6 Tissue Processing and Immunohistochemistry 
Seven weeks after injury, animals were anesthetized as described above and 
perfused transcardially with 300 mL of saline followed by 500 mL of ice-cold 4% 
paraformaldehyde (PFA) in 0.1M phosphate buffered saline (PBS).  Spinal cords 
were removed and post-fixed overnight in PFA at 4°C, then cryoprotected with 
30% sucrose and 0.2% sodium azide in PBS.  Serial transverse sections (40 µm) 
were cut in a 6-series from spinal cord segments rostral (T2/T3) and caudal 
(L2/L3) to the lesion and stored in PBS.   
Sections were fixed in absolute methanol on ice for 10 minutes, washed with 
PBS, and incubated in 2M HCl for 60 min at 37°C.  A twenty-minute rinse with 
0.1M borate buffer was used to neutralize the acid.  Following a PBS wash, the 
tissue was incubated in 5% normal goat serum (NGS), 5% normal donkey serum 
(NDS), and 1% bovine serum albumin (BSA) in 0.4% triton X-100/PBS at room 
temperature for 1 hour to permeabilize the tissue and block non-specific labeling.  
Treatment with primary antibodies occurred over two nights at 4°C in diluted 
blocking solution (1:3 in PBS).  The primary antibodies used were: rat anti-BrdU 
(1:150; Serotec MCA2060), rabbit anti-NG2 (1:250; Millipore AB5320), and 
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mouse anti-APC-CC1 (1:125; Calbiochem OP80).  The tissue was then 
incubated with secondary antibodies diluted in PBS for 2 hours at room 
temperature.  The secondary antibodies used were: donkey anti-rat Alexa 549 
(1:100; Jackson Immuno Research 712-505-153), and goat anti-rabbit (1:250; 
Molecular Probes A-11034) or anti-mouse (1:200; Molecular Probes A-11029) 
Alexa 488. 
3.2.7 Cell Quantification 
A stereology system (Stereoinvestigator, MBF Bioscience) was used to quantify 
the total number of dividing cells (BrdU+), oligodendrocyte progenitor cells 
(OPCs) (BrdU+/NG2+) and mature OLs (BrdU+/APC+) in the entire white matter.  
Tissue sections were outlined at low magnification (4x) to specify the sampling 
area, and quantification was performed at 60x.  The optical fractionator 
superimposed an unbiased grid (Figure 3.2) on the cross sections (thoracic: 375 
µm x 275 µm; lumbar: 300 µm x 450 µm).  The counting frame (80 µm x 80 µm), 
dissector height (12 µm), and guard zone distance (3 µm) were identical at all 
levels sampled.  Grid and counting frame dimensions were chosen so that 
quantification resulted in a coefficient of error less than or equal to 15%.  Ten 
sections per level were used for quantification.  Animals were excluded from 
statistical analysis if their BrdU+ cell counts were greater than 2 standard 
deviations from the mean.  Comparison between experimental groups and spinal 
cord levels was performed using a two- way ANOVA and Bonferroni post-test 
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(Graphpad Prism).  Statistical significance was accepted at p < 0.05, and all data 
are presented as mean ± SEM.   
3.3 Results 
3.3.1 FES Promotion of Cell Division is Frequency-dependent 
Previous work from our lab has shown that FES at 20 Hz promotes overall cell 
proliferation at L1 and L5 after a complete mid-thoracic spinal cord complete 
transection (Becker et al., 2010).  We sought to determine if this increase is 
dependent on the stimulation frequency.  Following a complete mid-thoracic 
transection (T9), adult rats were allowed to recover for 4 weeks, then received 3 
weeks of daily FES treatment at 2, 20, or 100 Hz (Figure 3.2).  Control animals 
not receive stimulation.  Daily injections of BrdU were delivered for 5 days prior to 
sacrifice to label dividing cells, and these cells were quantified in the entire white 
matter (WM) rostral and caudal to the injury level.  BrdU+ nuclei were distributed 
throughout the WM at both levels (Figure 3.3), but rarely detected in the gray 
matter (GM).  The highest concentration occurred in areas where the dorsal and 
lateral ascending sensory tracts are located.  At vertebral level T2/T3, BrdU 
incorporation was most evident in the dorsal columns and where lateral 
ascending sensory tracts are located.  Cell proliferation caudal to the lesion was 
also observed in the sensory tracts of the lateral and ventral WM, while lacking in 
the dorsal columns.  
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The number of BrdU+ cells rostral to the lesion was not influenced by FES 
treatment, regardless of stimulation frequency (Figure 3.2).  Complete spinal cord 
transection did not depress the number of dividing cells caudal to the lesion, in 
contrast to previous findings (Becker et al., 2010).  Animals that received 
stimulation at 20 Hz (36.07 ± 2.0; p < 0.01) and 100 Hz (34.05 ± 2.99; p < 0.05) 
had significantly enhanced cell proliferation relative to the control group (26.21 ± 
1.45) in the lumbar spinal cord, while animals in the 2 Hz group (33.51 ± 3.28) 
did not.  These results indicate that FES of the lower limbs modulates cell 
division in a frequency-dependent manner, and these changes are restricted to 
lumbar spinal cord.   
3.3.2 FES at 20 Hz Enhances OPC Proliferation 
Functional electrical stimulation is known to increase the number of neural 
progenitor cells in the lumbar spinal cord after a mid-thoracic transection (Becker 
et al., 2010).  To determine if FES frequency influences how many of these cells 
enter the OL lineage, we assessed the number of BrdU+ cells that became OPCs 
based on co-labeling with NG2.  OPC proliferation as a function of FES treatment 
or frequency remained unchanged above the injury level (Figure 3.4).  
Conversely, FES at 20 Hz augmented the number of BrdU+/NG2+ cells in the 
lumbar spinal cord to 13,831.87 ± 964.58, over a 50% increase relative to control 
animals (9,002.29 ± 1,043.39; p < 0.05) and those that received treatment at 2 
Hz (9,278.5 ± 894.32; p < 0.05).  Stimulation did not affect the number of BrdU+ 
cells that were co-labeled with NG2 between spinal cord levels.  These 
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observations suggest that 20 Hz is the optimal FES frequency to use in adult rats 
in order to maximize OPC proliferation in the lumbar spinal cord. 
3.3.3 Increased Proportion of Newborn OLs Between Spinal Cord 
Levels After FES Treatment 
Oligodendrocyte differentiation and myelination can be enhanced by electrical 
stimulation in vivo and in vitro (Impey et al., 2010; Q. Li et al., 2010; Malone et 
al., 2013).  We quantified the number of BrdU+ cells that also expressed APC in 
the injured spinal cord to assess if FES treatment at varying frequencies can 
augment OPC differentiation into mature OLs.  Stimulation did not impact the 
number of BrdU+ cells that were co-labeled with APC between experimental 
groups or spinal cord levels (Figure 3.5).  However, a greater proportion of these 
cells were observed caudally (40.34% ± 3.38) versus rostrally (26.5% ± 2.25) in 
animals that received stimulation at 20 Hz (data not shown; p < 0.05).  These 
findings indicate that FES at 20 Hz can increase the number of mature OLs in the 





Figure 3.1. Experimental design. 
Schematics illustrating the (A) experimental timeline, (B) FES electrode, and (C) 
electrode placement in adult rats.  (D) Schematic showing the stereological 
quantification of cells in the entire white matter of transverse spinal cord sections 






Figure 3.2. FES increases overall cell division. 
(A – B) Distribution of BrdU+ cells (red) in transverse spinal cord sections (A) 
rostral and (B) caudal to the spinal cord lesion.  (C) Animals that received FES 
treatment at 20 (p < 0.01) and 100 Hz (p < 0.05) had increased cell proliferation 
in the lumbar spinal cord relative to control animals.  Values displayed as mean ± 
SEM.   (control: 26.21 ± 1.45; 2 Hz: 33.51 ± 3.28; 20 Hz: 36.07 ± 2.00; 100 Hz: 






Figure 3.3. FES enhances OPC proliferation. 
(A) FES at 20 Hz increases the number of proliferating OPCs relative to control 
animals (p < 0.05) and those that received treatment at 2 Hz (p < 0.05) caudal to 
the SCI.  Values displayed as mean ± SEM.  (control: 9.0 ± 1.04, 2 Hz: 9.28 ± 
0.89, 20 Hz: 13.83 ± 0.96, 100 Hz: 12.19 ± 1.39).  (B) Schematic illustrating the 
location of the images C – G in transverse spinal cord sections.  (C – D) 
Representative images of the NG2+ cell distribution in the (C) dorsal columns and 
(D) ventral white matter caudal to the lesion.  (E – G) High-magnification images 






Figure 3.4. FES does not influence the number of mature OLs. 
(A – D) Representative images of BrdU+/APC+ cells in the (A, B) dorsal columns 
and  (C, D) lateral WM.  (B, D) High-magnification images from boxed areas in 
(A) and (C).  (E) The number of BrdU+ OLs was not affected by treatment group 
or spinal cord level. Values displayed as mean ± SEM. 
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Chapter 4: Short-term Functional 
Electrical Stimulation after Acute 
Spinal Cord Injury 
4.1 Chapter Overview  
Short-term electrical stimulation of nervous tissue can augment activity-
dependent mechanisms such as axonal regeneration and remyelination both in 
vivo and in vitro (Udina et al., 2008; Wan et al., 2010).  However, the effect of 
short-term ESTIM on oligodendrocyte (OL) development in vivo has not been 
fully investigated.  The purpose of this study was to assess if short-term FES 
treatment can enhance the development of adult oligodendrocyte progenitor cells 
(OPCs) harvested from the injured adult rat spinal cord.  Using immunopanning 
to isolate OPCs from rostral and caudal to a complete transection injury, we 
determined that one day of FES treatment at 20 Hz, given overnight prior to cell 




4.2.1 Experimental Design 
Adult, female Long Evans rats (200-250g upon arrival; Harlan) were injured at 
spinal cord level T9 and implanted with electrodes for FES as described above.  
After recovering for three days, animals received three one-hour sessions of FES 
treatment at 20 Hz overnight.  This frequency was chosen based on our previous 
finding that 20 Hz stimulation increases OPC proliferation in the injured adult 
spinal cord.  Control animals did not receive stimulation.   Oligodendrocyte 
progenitors were purified from injured adult rat spinal cords by sequential 
immunopanning and cultured as described below.   
4.2.1.1 Primary Cell Culture 
Oligodendrocyte progenitors were purified from the injured spinal cord of adult 
Long Evans rats by sequential immunopanning.  Two tissue segments (~15 mm 
long) equidistant from the injury site were excised from the spinal cord (Figure 
4.1).  Each segment was digested enzymatically with collagenase and papain (20 
units/ml), then passed through a 40-µm filter to remove cell aggregates.   The 
resulting cell suspension was incubated on an untreated Petri dish for 30 minutes 
at 37°C to remove microglia.  Non-adherent cells were then incubated Petri 
dishes coated with an anti-PDGFRα antibody (Abcam AB61219) for 1 hour at 
37°C to select the OPCs.  The purified cells were incubated with 0.05% trypsin 
for ~5 minutes and detached from the plate using a disposable cell scraper.  
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OPCs were plated at 500 cells/µl in 96-well plates coated with 10 µg/ml poly-D-
lysin (PDL) in differentiation or proliferation media. 
4.2.1.2 Media Components 
Differentiation Media: DMEM media supplemented with 0.5% fetal bovine serum 
(FBS; Hyclone), 1% glutamax, 1% sodium pyruvate, 1% nonessential amino 
acids, 8% n-acteyl cysteine, and a N1/N2 supplement (Sigma/Invitrogen).  
Mitogen withdrawal was used to induce differentiation. 
Proliferation Media: Differentiation media was supplemented with fibroblast 
growth factor (FGF, 10 ng/ml; Invitrogen), neurotrophin-3 (NT-3, 5 ng/ml; R&D 
Systems), a N1/N2 supplement, and platelet derived growth factor (PDGF, 
10ng/ml; R&D Systems) to keep OPCs in an undifferentiated state. 
4.2.2 Immunocytochemistry 
Cultures were fixed with 4% paraformaldehyde (PFA) for 10 minutes at room 
temperature or 30 minutes at 4°C.  Cells were blocked with 10% NGS and 0.1% 
triton in phosphate-buffered saline (PBS) for 1 hour at room temperature.  
Treatment with primary antibodies occurred over 2 hours at room temperature in 
the blocking solution.  Primary antibodies included rabbit anti-NG2 (1:250; 
Millipore), mouse anti-myelin basic protein (MBP, 1:1000; Calbiochem), mouse 
anti-BrdU (1:1000, Sigma), mouse anti-O4 (1:50), and mouse anti-O1 (1:50).  
Then the cultures were incubated with secondary antibodies goat anti-rabbit Cy3 
(1:250; Jackson Immmuno), goat anti-mouse Cy3 (1:250; Jackson Immmuno), or 
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goat anti-mouse IgM Alexa 488 (1:500; Invitrogen) for 1 hour at room 
temperature in PBS.  Nuclei were stained with Hoescht 33342 (1:2000; Molecular 
Probes). 
4.2.3 Cell Quantification 
Cells were counted by scanning the entirety of each well at 20x.  Experimental 
groups and spinal cord levels were compared using a two-way ANOVA and 
Bonferroni post-test (Graphpad Prism).  Significance was accepted at p < 0.05.  
All data is presented as the mean ± SEM. 
4.3 Results 
4.3.1 Short-term FES Does Not Modulate OPC Proliferation In 
Vitro 
Neural activity is required for OPC proliferation in CNS development (Barres & 
Raff, 1993), and can be used to increase the number of dividing progenitor cells 
in both the intact (Q. Li et al., 2010) and injured (Becker et al., 2010) spinal cord 
of adult rats.   In our first experiment, we wanted to determine if short-term 
stimulation could have a similar effect after an acute SCI.  Isolated OPCs were 
cultured for 3 days in proliferation media supplemented with BrdU to label 
dividing cells and fixed after 3 DIV.   Quantification of BrdU+ cells showed that 
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short-term FES does not modulate OPC proliferation in vitro regardless of the 
spinal level they originated from (Figure 4.1). 
4.3.2 OL Mean Elliptical Area is Not Influenced by FES Treatment 
As oligodendrocytes mature and begin myelination, they extend their cellular 
processes to locate and ensheath nearby axons.  We investigated the effect of 
FES on process extension by measuring the mean elliptical area of O1+ mature 
OLs after 7 DIV in differentiation media (Figure 4.1).  Mean elliptical areas did not 
differ between experimental groups or spinal cord levels, suggesting that OL 
process extension is not influenced by short-term FES. 
4.3.3 FES Enhances Differentiation of Harvested OPCs 
Next we wanted to determine if short-term FES influences OPC differentiation.  
Therefore, we cultured the harvested OPCs in mitogen-free differentiation media 
and fixed the cells after 1 or 7 days in vitro (DIV).  Antibodies against NG2 and 
O4 were used to label OPCs and immature OLs, while antibodies against O1 and 
MBP were used to identify mature OLs.  The percentage of cells expressing NG2 
or O4 did not change as a function of time in culture, FES treatment, or spinal 
cord level (Figure 4.2).   In control cultures, 50% of cells from above the injury 
were O1+ or MBP+ at 7 DIV.  In contrast, 12.37% ± 3.73 of cells were labeled with 
O1 (p < 0.05) and 24.58% ± 4.59 were labeled with MBP (p < 0.05), decreases of 
76% and 52% respectively.  Short-term FES at 20 Hz reversed the trend, 
elevating the number of O1+ and MBP+ to 56.4% ± 10.4 (p < 0.05; versus control) 
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and 64.87% ± 6.62 (p < 0.01; versus control).  These findings indicate that short-
term stimulation can enhance differentiation of adult OPCs isolated from the 
injured spinal cord into mature OLs. 
  
 54 
Figure 4.1: FES does not influence oligodendroglial proliferation or process 
elongation.   
(A) Schematic of SCI and OPC harvest sites. Short-term FES does not influence 
(B) OPC proliferation or (C) process elongation of mature OLs.  Values displayed 






Figure 4.2. FES increased OPC differentiation into mature OLs. 
Quantification of OPCs harvested from rostral and caudal to the lesion level after 
short-term FES and cultured in differentiation media for up to 7 days.  Cells were 
stained with antibodies against OL makers: (A) NG2, (B) O4, (C) O1, and (D) 
MBP to determine lineage progression.  Values displayed as mean ± SEM.  P-
values determined using two-way ANOVA followed by the Bonferoni post-test.  *p 




Chapter 5: Neural Activity Influences 
Oligodendrocyte Development by 
Modulating Epigenetic Mechanisms 
5.1 Chapter Overview 
Neural activity and epigenetic mechanisms, such as microRNAs (miRs) and 
chromtin remodeling by histone deacetylases (HDACs) and DNA methyl 
transferases (DNMTs), have been implicated in the control of oligodendrocyte 
(OL) development (Zuchero & Barres, 2013).  However, the interaction between 
these regulators of the oligodendrogenic program has yet to be determined.  We 
investigated the dynamics of these epigenetic modulators in OLs after electrical 
stimulation (ESTIM) in vitro, and in the injured rat spinal cord after functional 
electrical stimulation (FES) treatment.  Using quantitative real-time polymerase 
chain reaction (qRT-PCR), we determined that ESTIM alters the expression of 
the miR-17-92 cluster and miR-338 in co-cultures of primary spinal cord OPCs 
and dorsal root ganglia (DRG).  We found that a mid-thoracic complete 
transection results in miR dysregulation in the lumbar enlargement up to 2 weeks 
post-injury (PI), but FES at 20 Hz can delay the inhibition of miRs-138 and 338 
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while simultaneously upregulating the expression of miR-19b, DNMT1, and 
DNMT3b. 
5.2 Methods 
5.2.1 Primary Cell Culture and ESTIM 
Primary DRG and spinal cord OPCs were harvested from Sprague Dawley rats 
at postnatal day 4-5 (P4-5).  Dorsal root ganglia were allowed to mature in 
culture for 2 weeks, then harvested spinal cord OPCs were added to the culture 
(Figure 5.1).  One day after plating, co-cultures received one hour of electrical 
stimulation (ESTIM) at 20 HZ daily for up to 7 days in vitro (DIV).  Cells were 
fixed or harvested for RNA isolation immediately after the last ESTIM session.   
5.2.1.1 Dorsal Root Ganglia 
Dorsal root ganglia were isolated from neonatal rats (P4-5) based on a protocol 
described previously (Mehta et al 2007).  Rat pups were anesthetized with 
isoflourane and sacrificed by decapitation.  The ventral skin was incised, and the 
rib cage and internal organs removed.  Starting rostrally, the ventral vertebrae 
were cut to reveal the entire spinal cord.  Dissected DRGs and spinal cords were 
stored in L-15 media on ice until enzymatic digestion. 
Harvested DRGs were incubated in collagenase (2 mg/ml in L15 media) for 30 
minutes, followed by 0.25% trypsin (Invitrogen) for 45 minutes, both at 37°C.  
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Dissociated cells were passed through a 40-µm filter to remove cell aggregates, 
then incubated on a laminin-coated (10 µg/ml) Petri dish for 1 hour at 37°C.  The 
non-adhered DRGs were collected and diluted in neurobasal media 
supplemented with 1% glutamax, 0.5% penn strep, 5% FBS, a B27 supplement 
(Invitrogen), and 100 ng/ml nerve growth factor (NGF, 100 ng/ml; Sigma).  
Dissociated cells were plated in 48 well plates coated with 10 µg/ml of poly-D-
lysine (PDL) at a concentration of 75,000 cells per 250 µl.  Ara-C (5 µM) was 
added for 4 days to minimize astrocyte proliferation. 
5.2.1.2 Neonatal OPCs 
Spinal cord OPCs were isolated from Sprague Dawley rat pups at P4-5.  
Dissected spinal cords were minced into small pieces with a scalpel blade (#10) 
and incubated in collagenase (2 mg/ml) in L15 media for 30-40 minutes at 37°C.  
The tissue was further digested in 0.25% trypsin with EDTA (Invitrogen) for 20-30 
minutes at 37°C and passed through a 40-µm filter.   Dissociated OPCs were 
diluted in proliferation media and plated at 800 cells/ml in flasks coated with PDL 
(10 µg/ml) until confluence.   
For ESTIM experiments, OPCs were co-plated with DRG cultures at 30,00 
cells/well (400 cells/mm2) in differentiation media. One day after plating, co-
cultures received one hour of ESTIM at 20 HZ daily for up to 7 days in vitro (DIV).   
5.2.1.3 Electrical Stimulation 
Lids of 48 well culture plates were retrofitted with pairs of platinum wire 
electrodes.  The electrodes extended into the cell culture media and, to ensure 
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equal stimulation current in all wells, were connected in series by stainless steel 
wire.  A MultiStim System D-330 stimulator (Digitimer Ltd) (Fields et al 1990; 
Balkowiec and Katz 2000), connected to the lids with alligator clips, delivered 
biphasic pulses (6 mA, 200 µs) to induce action potentials in DRGs.  Pulses 
lasted for 500 ms and occurred every 2 sec.  Electrodes extended into all wells, 
but those in control wells were not connected to the stimulator, and therefore did 
not receive any stimulation. 
5.2.1.4 Immunocytochemistry 
Co-cultures were fixed with 4% PFA for 45 minutes at 4°C and -20°C methanol 
for 3 minutes on ice, followed by blocking for 1 hour at room temperature with 
10% NGS and 0.4% triton in PBS.  Treatment with primary antibodies occurred 
overnight at 4°C in the blocking solution, followed by incubation with secondary 
antibodies for 1 hour at room temperature in PBS.  Primary antibodies used 
were: rabbit anti-NG2 (1:1000; Millipore), mouse anti-MBP  (1:1000; 
Calbiochem), and chicken anti-neurofilament (NF, 1:1000; Millipore).  Goat 
secondary antibodies from Jackson Immuno (1:250) included anti-mouse Alexa 
488, anti-rabbit Cy3, and anti-chicken Cy5.   
5.2.1.5 Cell Quantification 
For ESTIM experiments, MBP+ cells were counted at 20x during a single vertical 
pass from electrode to electrode in each well (Figure 5.1).  Comparison between 
experimental groups and spinal cord levels was performed using a two- way 
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ANOVA and Bonferroni post-test (Graphpad Prism).  Significance was accepted 
at p < 0.05, and all values are displayed as mean ± SEM. 
5.2.2 Animals and FES Treatment 
Adult, female Long Evans rats (200-250g upon arrival; Harlan) received a 
complete spinal cord transection injury at verterbral level T9 as described above.  
Electrodes were implanted in the tibiailis anterior muscle of both hindlimbs 4 days 
later, and animals were allowed to recover for 3 days.  FES treatment, three 1-
hour sessions per day at 20 Hz, began 1 week after injury and lasted either 1 or 
7 days (Figure 5.5).  Spinal cord tissue from the lumbar enlargement was then 
harvested for RNA isolation.  Experimental groups (n = 3 per group) were: 
1) Uninjured control 
2) SCI 
3) SCI and FES (20 Hz)  
5.2.3 Quantitative Real-Time Polymerase Chain Reaction 
Co-cultures of DRGs and OPCs received ESTIM for 1, 4, or 7 days in mitogen-
free media.  Cells from 6 wells were combined and lysed with QIAzol lysis 
reagent (700 µl; Qiagen 79306).  The combined lysates were then homogenized 
by vortexing for one minute, and the total RNA extracted as described below. 
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Adult rats were anesthetized as described previously and sacrificed by 
decapitation.  The lumbar enlargement (1.5mm long) was excised and 
immediately immersed in RNAlater RNA Stabilization Reagent (1 ml; Qiagen 
76106) to stabilize RNA.  Tissue was stored at -20°C until disruption and 
homogenization by pestle (Kimble Chase 749515-1500) in QIAzol lysis reagent 
(700 µl/25 mg tissue; Qiagen 79306).  
Total RNA was isolated from tissue and cell homogenates using the miRNeasy 
Mini kit (Qiagen 217004) and treated with DNase (Qiagen 79254) to remove 
residual amounts of DNA.    The miScript II RT Kit (Qiagen 218161) was used for 
reverse transcription of total RNA, including microRNA, into cDNA. 
MicroRNA and mRNA expression was determined using the miScript SYBR 
Green PCR Kit (Qiagen 218075). Quantitative real-time polymerase chain 
reaction was performed according to Qiagen’s protocol: 
• 15 min PCR initial activation step (95°C) 
• 3 step cycling (40 cycles total) 
o 15 sec denaturation (94°C) 
o 30 sec annealing (55°C) 
o 30 sec extension (70°C) – fluorescence data collection 
• Melt curve (55°C to 95°C; 0.5°C steps) 
The miScript miRNA PCR Array (Qiagen MIRN-107Z) was used to quantify the 
expression of 86 miRs expressed during development and disease in the rodent 
nervous system.  qRT-PCR using the PCR array was performed on the iCycler 
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IQ5 (Bio-rad).  Individual miScript Primer Assays and QuantiTect Primer Assays 
(Qiagen) were used to measure expression of OL-specific microRNAs and 
mRNAs, respectively, isolated from spinal cord tissue.  qRT-PCR using individual 
primers was performed on the CFX Connect™ Real-Time PCR Detection System 
(Bio-rad 185-5201).  Values were normalized to those from control cultures after 
1 day in vitro or from naïve, uninjured animals.  
Fold change was calculated using the 2-ΔΔCt method (Livak & Schmittgen, 2001).  
Measurements were normalized to the expression of U6 small nuclear 2 RNA 
(RNU6-2) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for miRs 
and mRNAs, respectively.  Comparison between experimental groups was 
performed using a two-way ANOVA and Bonferroni post-test (Graphpad Prism).  
Significance was accepted at p < 0.05, and all values are displayed as mean ± 
SEM. 
5.3 Results 
5.3.1 Mitogen Withdrawal and ESTIM Increase OL Differentiation 
Neural activity is required for OPC proliferation in the developing optic nerve 
(Barres & Raff, 1993), and ESTIM is known to promote OL survival and 
myelination in vitro (Gary et al., 2012; Malone et al., 2013).  However, the role of 
ESTIM in epigenetic control of OL development is unknown.  To determine 
whether epigenetic mechanisms in OL lineage cells is modulated by neuronal 
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activity, we cultured P4 rat spinal cord DRGs and OPCs together in mitogen-free 
media and applied 1 hour of daily ESTIM at 20 Hx for up to one week (Figure 
5.1).  In control cultures, the number of mature OLs increased from 36.25 ± 1.15 
at 1 DIV to 96.75 ± 1.83 at 4 DIV, a 167% change.  A further 12% elevation in OL 
numbers occurred at 7 DIV, bringing the total number of mature OLs to 108 ± 
0.54.  The same temporal trend was observed in the stimulated cultures, where 
myelinating OLs numbered 41.25 ± 2.67, 109.25 ± 3.64, and 121 ± 2.46 after 1, 
4, and 7 days of ESTIM.  Treated wells had 12-13% more MBP+ OLs than control 
wells only at 4 and 7 DIV (p < 0.01).  These findings confirm previous findings 
(Gary et al., 2012; Malone et al., 2013), indicating that neural activity increases 
the number of  MBP+ OLs in vitro.    
5.3.2 ESTIM Modulates Expression of OL Lineage-Specific 
microRNAs in DRG/OPC Co-cultures 
Next, we analyzed the expression of several components of the miR-17-92 
cluster (Figure 5.2), which is known to regulate OPC proliferation (Budde et al., 
2010; De Faria Jr et al., 2012).  After 4 days in culture, miR-19a and miR-92a 
were enhanced to 4.21 ± 0.17 (321%) and 4.02 ± 0.32 (302%), respectively, 
relative to baseline (p < 0.001).  By the seventh day in culture, the levels of both 
miRs decreased to 2.59 ± 0.38 and 2.14 ± 0.10, respectively, and were no longer 
significantly upregulated. Expression of miRs-19b, 20a in control cultures did not 
change over time.  Four doses of ESTIM increased miRs-19a, 20a, and 92a to 
3.89 ± 0.47 (289%; p < 0.001), 2.99 ± 0.44 (199%; p < 0.01), and 2.75 ± 0.38 
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(175%; p < 0.01), respectively, but it suppressed miR-92a expression by 32% 
versus control (p < 0.05).  Only miR-92a remained elevated after 7 days of 
ESTIM at 2.61 ± 0.46 (161%; p < 0.01).  These findings suggest that the miR-17-
92 cluster, previously identified as a promoter of OPC cell proliferation, may also 
be involved regulating in OL differentiation, and that it can be influenced by 
neural activity. 
Prior studies have identified miRs-138 and miR-338 as modulators of OL 
differentiation (De Faria Jr et al., 2012; Dugas et al., 2010; Zhao et al., 2010), 
and miR-23a has been shown to regulate OL myelination (S.-T. Lin & Fu, 2009; 
S. Lin et al., 2013).  We measured the expression of these miRs in DRG/OPC 
co-cultures treated with daily ESTIM to determine if they play a role in activity-
dependent OL development.  None of these OL-specific miRs were significantly 
changed as the OPCs differentiated into mature OLs over 7 days in control 
cultures (Figure 5.2).  Four doses of ESTIM elevated miR-338 levels to 1.97 ± 
0.19, a 97% increase relative to the baseline (p < 0.05), and a 52% elevation 
when compared to a single dose (1.36 ± 0.64; p < 0.01).  miR-338 expression 
dropped 73% to 0.53 ± 0.35 (p < 0.001) after an additional 3 days of ESTIM. Four 
doses of ESTIM resulted in upregulation of miR-338 expression relative to 
baseline values (p < 0.05) and to a single day of ESTIM (p < 0.01).  In contrast, 
miRs-138 and 23a were not influenced by cell maturation or neural activity. This 
ESTIM-induced upregulation of miR-338 indicates that this miR may play a role 
in the increased number of MBP+ OLs observed after 4 stimulation sessions.   
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5.3.3 Changes in OL-specific miRs are Not Found in Stimulated 
DRG Cultures 
To ensure that the observed changes in miR levels were occurring specifically in 
OL lineage cells, we stimulated cultures of DRGs alone for 4 days.  None of the 
miRs investigated changed over time or after ESTIM treatment (Figure 5.3).  
Taken together, these results suggest that alterations in miR levels in the 
DRG/OPC cultures are restricted to the OL lineage cells.  Prior work has shown 
that neurons are necessary for ESTIM to augment OL numbers in vitro (Gary et 
al., 2012).  Therefore, we did not measure miR levels in cultures of primary 
OPCs.  
5.3.4 microRNA Dsyregulation in the Lumbar Enlargement after 
Acute SCI 
Acute SCI in rodents results in miR dysregulation around the injury site, with the 
vast majority of miRs suppressed relative to sham animals (Bhalala et al., 2012; 
N.-K. Liu et al., 2009; Nakanishi et al., 2010; Ryge et al., 2010; Strickland et al., 
2011; Yunta et al., 2012; Ziu et al., 2013).  To assess if an acute SCI can 
influence epigenetic mechanisms distant to the injury level, we gave adult female 
rats a complete transection at T9, and measured miR expression in the lumbar 
enlargement 8 or 14 days later.  As previously reported, the vast majority of miRs 
studied were downregulated in the lumbar enlargement at one or both time points 
following the SCI (Figure 5.4).  This miR dysregulation in the lumbar 
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enlargememt indicates that acute SCI can effect epigenetic regulation up to 5 
vertebral levels from the injury site. 
5.3.5 One Day of FES Treatment Modulates Levels of OL-specific 
miRs in the Injured Spinal Cord 
FES treatment after chronic SCI increases the proliferation of neural precursor 
cells (Becker et al., 2010) and OPCs (Figure 3.3) in the lumbar spinal cord of 
adult rats.  We sought to determine if microRNAs might mediate these 
proliferative effects in vivo.  Adult rats received a complete mid-thoracic 
transection, followed by 1 or 7 days of FES treatment starting a week after the 
injury (Figure 5.5).  RNA was harvested from the lumbar enlargement, which is 
expected to have enhanced neural activity as a result of FES.   
microRNA-124 is known to regulate NPC proliferation and differentiation (Cheng 
et al., 2009; Yoo et al., 2009), while miR-9/9* and the miR-17-92 cluster are 
involved in maintaining OPC numbers (Budde et al., 2010; Lau et al., 2008).  SCI 
did not affect the level of these miRs at either time point (Figure 5.5).  One day of 
FES suppressed miR-124 expression to 0.67 ± 0.06, a 33% decrease relative to 
baseline (p < 0.05), but the inhibition disappeared by the 7th day of treatment.  
miR-19b, part of the miR-17-92 cluster, was augmented by a single day of FES 
to 1.16 ± 0.06, a 34% increase versus untreated animals (p < 0.05), but returned 
to control levels after 7 days of stimulation.  Neither SCI, nor FES, influenced the 
expression of miR-9/9* at either time point.  Taken together, these results 
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suggest that a single day of FES treatment may influence OPC proliferation by 
modulating miR-124 and miR-19b levels. 
Several miRs control OL differentiation and myelination, including miRs-138, 219, 
338, and 23a (J.-S. Li & Yao, 2012).  Eight days after the complete thoracic SCI, 
miR-338 levels were suppressed to 0.72 ± 0.06 (-28%; p < 0.05), and the 
inhibition continued for up to 2 weeks post-injury (WPI) where miR-338 
expression was 0.58 ± 0.07 (-23%; p < 0.05) (Figure 5.5).  microRNA-23a 
displayed a similar temporal pattern, dropping to 0.59 ± 0.10 (-41%; p < 0.05) 
and 0.65 ± 0.05 (-35%; p < 0.05) at 8 and 14 DPI, respectively.  FES treatment 
delays this inhibition until 2 WPI, when the fold change in expression of miR-338 
was 0.72 ± 0.09 (-28%; p < 0.05) and miR-23a was 0.59 ± 0.07 (-41%; p < 0.05).  
In contrast, miR-138 and miR-219-1-5p (data not shown) were unchanged after 
SCI and/or FES treatment.  Dicer1, the enzyme that cleaves precursor miR to 
generate the mature miR transcript, was also unchanged between experimental 
groups.  These observations demonstrate that the FES-mediated return of 
patterned neural activity to the lumbar spinal cord can influence miR-338 and 
miR-23a levels, possibly influencing the extent of OL differentiation and 
remyelination after SCI. 
5.3.6 Neural Activity Upregulates DNMT Expression After Acute 
SCI 
Additional ways of regulating OL development epigenetically include DNA 
methylation and chromatin remodeling.  Developing nervous system tissue has 
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elevated levels of DNA methyltransferases (DNMTs), which decline during 
differentiation (Simmons et al., 2013), and synaptic activity increases the extent 
of DNA methylation (Levenson et al., 2006).  Histone deacetylases (HDACs) 
alleviate negative regulation of OPC differentiation by removing acetyl groups 
from chromatin, thereby promoting OL lineage progression (Conway, O’Bara, 
Vedia, Pol, & Sim, 2012; Fancy et al., 2011; Wood et al., 2013; Ye et al., 2009).  
We used qRT-PCR to assess mRNA expression of the major DNMTs (DNMT1, 
3a, and 3b) and HDAC1/2 in the lumbar spinal cord of adult rats after a complete 
acute transection at T9 and FES treatment (Figure 5.6).  Of the 3 DNMTs 
investigated, only DNMT1 was influenced by SCI, rising 37% to 1.37 ± 0.04 at 2 
WPI (p < 0.01).  One day of FES increased DNMT1 expression to 1.29 ± 0.09, a 
29% change from baseline (p < 0.05) and a 26% growth relative to control 
animals (p < 0.05).  Short-term stimulation had a similar effect on DNMT3b 
levels, which rose to 1.47 ± 0.21, representing a 47% and 57% enhancement 
versus baseline (p < 0.01) and unstimulated (p < 0.05) animals, respectively.  
Expression of HDACs1 and 2 was not influenced by SCI or FES treatment.  




Figure 5.1. ESTIM promotes myelination in DRG/OPC co-cultures. 
(A) Schematic of the experimental time line.  (B – D) Representative images of of 
co-cultures at (B) 1, (C) 4, and (D) 7 DIV.  Scale bars = 25 µm.  (E) Schematic of 
cell quantification during a single vertical scan from electrode to electrode.  (F) 
Quantification of MBP+ cells.  Data presented as mean ± SEM.  **p < 0.01 (two-






Figure 5.2. ESTIM alters expression of OL-specific miRs. 
Quantification of (A) the miR-17-92 cluster and (B) miRs-138, 338, and 23a in 
OPC/DRG co-cultures treated with daily ESTIM at 20 Hz for up to 1 week.  
Expression was calculated using the 2-ΔΔCt method and normalized to control 
values at 1 DIV.   RNU6-2 was used as an internal control.  Data represent mean 
± SEM.  P-values determined using two-way ANOVA followed by the Bonferoni 




Figure 5.3. ESTIM does not influence miR expression in primary DRG 
cultures. 
Quantification of miR expression in cultures of primary DRGs treated with daily 
ESTIM at 20 Hz for up to 4 days. Neural activity does not influence the 
expression of (A) the miR-17-92 cluster or (F) miRs-138,  miR-338, or miR-23a.  
Expression was calculated using the 2-ΔΔCt method and normalized to control 
values at 1 DIV.   RNU6-2 was used as an internal control.  Data represent mean 
± SEM.  P-values determined using two-way ANOVA followed by the Bonferoni 






Figure 5.4. miR dysregulation in the lumbar enlargement after acute SCI. 
microRNAs that are (A) upregulated or (B – C) suppressed following acute SCI. 
Expression was calculated using the 2-ΔΔCt method and normalized to uninjured 





Figure 5.5. FES alters expression of OL-specific miRs. 
(A) Schematic of the experimental timeline.  Quantification of OL-specific miRs 
that regulate (B) OPC proliferation and (C) OL maturation.  (D) Levels of Dicer1 
mRNA after SCI and FES treatment.  Expression was calculated using the 2-ΔΔCt 
method and normalized to uninjured control animals.   RNU6-2 and GAPDH were 
used as internal controls for miRs and mRNA, respectively.  Data represent 




Figure 5.6. Expression of DNMT1/3b is upregulated by FES treatment. 
mRNA expression levels of (A) DNA methyltransferases and (B) histone 
deacetylases in the lumbar enlargement after 1 or 7 days of FES treatment at 20 
Hz.  Expression was calculated using the 2-ΔΔCt method and normalized to 
uninjured control animals. GAPDH was used as the internal controls.  P-values 
determined using two-way ANOVA followed by the Bonferoni post-test (n = 3).  *p 




Chapter 6: Discussion 
6.1 Frequency-dependent Regulation of OL 
Development in the Chronically Injured Adult 
Spinal Cord 
The frequency-dependent effects of ESTIM on cells of the nervous system have 
been demonstrated previously (Balkowiec & Katz, 2000; Gary et al., 2012; B 
Stevens et al., 1998).  In co-cultures of Schwann cells and DRGs, myelination 
was suppressed by ESTIM at 0.1 Hz, but unaffected by 1 Hz stimulation (B 
Stevens et al., 1998).  Electrical stimulation at 10 Hz, but not 1 or 100 Hz, 
increased the number of MBP+ OLs in cultures of rat cortical neurons and OPCs 
(Gary et al., 2012).  We found that the number of BrdU+ cells in the injured spinal 
cord of adult rats is elevated by FES at 20 Hz or 100 Hz, while the number of 
BrdU+/NG2+ cells, indicative of OPC proliferation, is significantly higher after FES 
at 20 Hz group.  These findings indicate that 20 Hz is the optimal stimulation 
frequency to maximize the number of proliferating OPCs after SCI. 
Neural activity promotes OPC differentiation (Q. Li et al., 2010), in addition to OL 
myelination and viability (Gary et al., 2012; Malone et al., 2013), through several 
mechanisms, including purinergic signaling (Beth Stevens, Porta, Haak, Gallo, & 
Fields, 2002) and activity-induced secretion of LIF from astrocytes (Ishibashi et 
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al., 2006).  We determined that the number of BrdU+ OLs in the chronically 
transected rat spinal cord was not significantly changed after FES treatment, 
regardless of stimulation frequency.  In contrast, Li et al. (2010) found increased 
BrdU incorporation in dorsal column OLs after ESTIM of the contralateral 
pyramidal.  The lack of an FES-induced effect on OPC differentiation in our 
experiments may be due to the animal survival time after BrdU injection.  OPC 
division rates in the rodent cortex, corpus callosum, optic nerve, and spinal cord 
decline with age (Young et al., 2013).  By P60, the total cell cycle time for OPCs 
in spinal cord white matter increases to ~15 days (Young et al., 2013), likely due 
to an extended G1 phase (Simon, Götz, & Dimou, 2011).  Although CNS injury 
causes adult OPCs to proliferate 5x faster than normal (Simon et al., 2011), it 
also delays their differentiation into mature OLs (Sim, Zhao, Penderis, & Franklin, 
2002).  Taken together, these findings suggest that additional survival time after 
BrdU pulse labeling might be necessary to observe increased OPC differentiation 
after FES. 
6.2 Proliferation and Differentiation of Harvested 
OPCs after Short-term FES 
The effect of ESTIM on glial cells is dependent on the stimulation frequency and 
the number of stimulation sessions.  Although 1 hour of ESTIM is sufficient to 
increase both the onset and extent of Schwann cell myelination of DRG axons in 
vitro and in vivo (Wan et al., 2010), at least 3 daily 1-hour sessions are required 
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to promote myelination in OPC/DRG co-cultures (Malone et al., 2013).  We found 
that 3 FES sessions (20 Hz), delivered on the 7th day after an acute thoracic 
transection, increased the differentiation of OPCs harvested from the lumbar 
enlargement and cultured in mitogen-free media.  However, previous work shows 
ESTIM promotes OL viability and myelination without influencing differentiation 
(Gary et al., 2012; Malone et al., 2013).  These conflicting results may be due to 
differences in experimental design.  Gary et al. used embryonic mixed cortical 
cultures, and let the primary OPCs mature for 3 days prior to ESTIM application, 
which is enough time for the vast majority of OPCs to differentiate into 
GalC+MBP+ OLs (Dugas, Tai, Speed, Ngai, & Barres, 2006).   
Our experiments also show that short-term FES does not increase proliferation of 
harvested adult OPCs in the presence of PDGF, suggesting that additional days 
of stimulation might be necessary to enhance the proliferative ability of these 
cells.  However, both PDGF and bFGF are required to keep adult OPCs from the 
spinal cord or optic nerve require to remain actively dividing and undifferentiated 
in vitro (Engel & Wolswjk, 1996; Wolswjk & Noble, 1992).  In the presence of 
PDGF alone, adult OPCs divide slowly and give rise to OLs by asymmetric 
division and differentiation (Engel & Wolswjk, 1996).  This suggests that the lack 
of a difference in OPC proliferation between the control and stimulated animals is 
due to the absence of a key mitogen in the proliferation media.  Further work is 
needed to determine if short-term FES can influence the division rate of adult-
born OPCs. 
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6.3 Activity-dependent Regulation of Epigenetic 
Mechanisms in Oligodendroglial Cells 
The degree of neurological impairment after SCI depends on the extent of the 
secondary damage after the initial injury, functionality of remaining tissue, and 
endogenous repair mechanisms such as remyelination.  Studying the molecular 
changes that occur in OL lineage cells is paramount in understanding the role of 
activity-based therapy after SCI.  Neural activity has been implicated in regulating 
OL biology and miR expression (Eacker, Dawson, & Dawson, 2013; Eacker, 
Keuss, Berezikov, Dawson, & Dawson, 2011; Nudelman et al., 2010; Ryan, 
Donovan, & McLoughlin, 2013; Wibrand et al., 2010).  Our experiments are the 
first to show that neural activity modulates OL-specific miRs in OPC/DRG co-
cultures and in the injured adult rodent spinal cord.   
6.3.1 Modulation of Epigenetic Mechanisms In Vitro 
6.3.1.1 The miR-17-92 Cluster 
Mitogen withdrawal is known to induce OPC differentiation in vitro by 
upregulating miRs-219, -138, and -338 (Dugas et al., 2010).  Our experiments 
are the first to demonstrate that OPC differentiation after mitogen withdrawal also 
elevates the expression of miR-17-92 cluster components.  In contrast, De Faria 
et al. (2012) showed that levels of miR-20a and miR-92a are reduced at 5 and 8 
DIV, while miR-19a and miR-19b aren’t suppressed until 8 DIV, in primary 
cultures of cortical OPCs from P0 rats.  Differences between our data and these 
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published results might be due to the anatomical origin of the cells and the media 
components.  Dicer1 ablation, under the control of the CNP promoter, has 
different effects on the number of Olig2+ cells in the P0 rodent brain and spinal 
cord, suggesting that OL development is regulated by distinct mechanisms in 
these anatomical regions (Budde et al., 2010).  Additionally, the media used in 
De Faria’s study contained triiodothyronine (T3), which exacerbates the effect of 
mitogen-withdrawal on miR expression in OL lineage cells (Dugas et al., 2010). 
These data are the first to show that ESTIM influences expression of OL-specific 
miRs in co-cultures of OPCs and DRG, and that the changes in expression were 
dependent on the number of ESTIM sessions.  Four daily sessions of ESTIM 
were required to upregulate components of the miR-17-92 cluster, supporting the 
conclusion that ESTIM-mediated effects in OL lineage cells are a function of 
session number (Malone et al., 2013).  In addition to promoting cell division, 
increased expression of miR-20a and miR-92a also enhances cell viability by 
preventing apoptosis in cancer cells (Niu et al., 2012; Sharifi, Salehi, Gheisari, & 
Kazemi, 2013, 2014; Tian, Fang, Xue, & Chen, 2013; Q. Wu et al., 2013).  The 
elevation of these miRs after ESTIM treatment may have a similar effect on the 
OL lineage cells in our experiments, possibly underlying the increased number of 
mature OLs observed in stimulated cultures from this study and from previous 
work (Gary et al., 2012).  
We also found that the miR-17-92 cluster is regulated temporally by both mitogen 
withdrawal and ESTIM treatment.  microRNA-20a modulates expression of the 
E2F family of transcription factors (Sylvestre et al., 2007), which controls OPC 
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cell cycle exit (Magri et al., 2014).  E2F1-3 binds to the miR-17-92 promoter, 
creating a feedback loop to prevent precocious cell proliferation (Sylvestre et al., 
2007).  These findings suggest that a similar feedback loop is present in 
oligodendrolia and is responsible for the temporal regulation of the miR-17-92 in 
vitro.  
6.3.1.2 Differentiation- and Myelination-Promoting miRs 
Increased expression of miR-138 and miR-338 initiates the transition from cycling 
OPC to immature OL by targeting PDGRFa, FGFR2, Hes5, Sox6, and 
UHRF1bp1, while elevated miR-23a promotes myelination by inhibiting laminB1 
(Dugas & Notterpek, 2011).  We found that these miRs don’t change significantly 
as OPCs mature over time, in sharp contrast to prior studies (De Faria Jr et al., 
2012; Dugas et al., 2010).  In addition, ESTIM only upregulated miR-338 after 4 
days of treatment, while miR-138 and miR-23a were unaffected at all time points, 
despite the increased number of MBP+ OLs observed after 4 and 7 days of 
ESTIM.  These unexpected results might be due to miR expression in the DRG 
cell bodies and/or axons.  The miRs mentioned above are considered to be 
specific to the OL lineage because their expression is much higher in OLs than in 
astrocytes, neurons, or DRGs (Budde et al., 2010; Dugas et al., 2010; Hua et al., 
2009).  However, our data show that they are still detectable in primary cultures 
of DRGs.  We attempted to rule out effects of miR changes in DRGs by 
quantifying miR expression in primary DRG cultures with and without ESTIM, and 
found that none of the miRs mentioned above changed significantly over time or 
in response to stimulation.   However, OL lineage cells can communicate with 
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axons via neurotransmitter-mediated release of exosomes (Frühbeis et al., 
2013).  These exosomes contain proteins and RNA, includning miRs (Pusic & 
Kraig, 2014), possibly influencing miR expression in the DRGs that aren’t evident 
when DRGs are stimulated alone. Therefore it is possible that our results may be 
due to variations in miR levels in DRGs.  Further work is required to identify 
activity-dependent miR changes specifically in OL lineage cells treated with 
ESTIM. 
6.3.2 Modulation of Epigenetic Mechanisms In Vivo 
Following an acute SCI in adult rats, the miR network is dysregulated around the 
lesion site (N.-K. Liu et al., 2009; Nakanishi et al., 2010; Strickland et al., 2011; 
Yunta et al., 2012; Ziu et al., 2013).  Our experiments show that this 
dysregulation also occurs 4-8 levels caudal to the lesion for up to 14 DPI.  The 
majority of miRs in our experiments were downregulated, in accordance with 
previous studies (N.-K. Liu et al., 2009; Strickland et al., 2011; Yunta et al., 
2012).  However, our data are the first to show that alterations in miR levels after 
acute SCI are independent of Dicer1, the protein that synthesizes mature miRs, 
expression. 
6.3.2.1 Lineage Specification and Cell Proliferation 
In the first few weeks after SCI, endogenous OPCs migrate to the lesion site and 
proliferate extensively and replace OLs lost to necrosis and apoptosis.  Previous 
studies have observed upregulation of miR-17-92 cluster components miR-17, 
miR-20, and miR-19a within and around the lesion (N.-K. Liu et al., 2009; Yunta 
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et al., 2012), which may contribute to the increased OPC proliferation typically 
observed after SCI.  Our data show that these alterations do not extend caudally 
into the lumbar enlargement within the first 2 weeks after injury.  This suggests 
that the dysregulation of the miR-17-92 cluster may play a role in the spatial 
regulation of OPC proliferation after actue SCI.  We also found that one day of 
FES treatment increases the expression of miR-19b.  Prior work has shown that 
miR-19b, the most abundant component of the miR-17-92 cluster, enhances 
OPC proliferation through Pten/Akt signaling (Budde et al., 2010).  Taken 
together, these findings indicate that the FES-induced elevation in miR-19b may 
promote OPC proliferation in the injured spinal cord, and might be responsible for 
the increased OPC division we observed after FES treatment in chronically 
injured animals.   
6.3.2.2 Differentiation- and Myelination-Promoting miRs 
Numerous factors contribute to OL death from necrosis and apoptosis after SCI, 
including ischemia, inflammation, glutatamate excitotoxicity, hypoxia, and free 
radicals (Mekhail, Almazan, & Tabrizian, 2012).  In animal models of SCI, the 
resulting demyelination is observed within the first 24 hours after injury, followed 
by a second wave of OL death and enhanced demyelination 3 weeks PI (Griffiths 
& McCulloch, 1983; Totoiu & Keirstead, 2005).  By 14 DPI, OL apoptosis extends 
several millimeters rostrocaudally from the injury site, while neuronal apoptosis is 
restricted to the lesion (Crowe, Bresnahan, Shuman, Masters, & Beattie, 1997; X. 
Z. Liu et al., 1997).  These findings suggest that the decreased expression of 
miR-338 and miR-23a that we observed at 8 and 14 DPI is due to elevated OL 
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death and demyelination after SCI. However, miR-138 and miR-219 are not 
influenced by SCI, contradicting this theory.  ESTIM promotes OL viability and 
survival in vitro, resulting in increased numbers of MBP+ OLs in mixed cortical 
cultures (Gary et al., 2012).  FES may have a similar effect in vivo, possibly 
delaying miR-338 and miR-23a inhibition by enhancing OL viability in the injured 
spinal cord. 
6.3.2.3 DNA Methylation  
As discussed previously, DNMTs and HDACs can also influence OL 
development.  Our data show that SCI induces DNMT1 activity, but not until 14 
DPI.  In contrast, FES treatment promotes both earlier and elevated DNMT1 
expression at 7 DPI.  Since DNMT1 is a maintenance DNMT, responsible for 
passing on established methylation patterns to the newly replicated DNA in 
daughter cells (MacDonald & Roskams, 2009), its FES-induced increase is 
possibly due to enhanced division of OPCs.  DNMT1 activity in NPCs is also 
required for neurogenesis at the expense of astrocyte differentiation (Juliandi et 
al., 2010), suggesting that it might be responsible for the increased number of 
nestin+ cells found after FES treatment (Becker et al., 2010).  However, DNMT1 
suppression is neuroprotective after ischemia-induced injury (MacDonald & 
Roskams, 2009), underscoring the complicated role it plays after CNS injury. 
 88 
6.4 Concluding Remarks 
Currently, most research initiatives for improving remyelintion focus on the 
transplantation of myelinating cells into the injury site or delivering factors that 
increase OL survival and development.  However, FES provides a noninvasive 
option for generating neural activity in the injured nervous system to regulate OL 
biology.  Functional remyelination following CNS injury or disease may require 
manipulation of all the phases of OL development in order to replace OLs and 
successfully ensheath spared axons.  Therefore it is important to assess the 
intrinsic molecular changes that occur in OL lineage cells in the injured CNS, and 
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